Pyrido-pyrazine derivatives useful as herbicidal compounds

专利摘要:

公开号:AU2007331307A1
申请号:U2007331307
申请日:2007-12-06
公开日:2008-06-19
发明作者:Neil Brian Carter；Matthew Robert Cordingley；Patrick Jelf Crowley；Michael Drysdale Turnbull
申请人:Syngenta Ltd；
IPC主号:C07D471-04

专利说明:
WO 2008/071918 PCT/GB2007/004662 PYRIDO-PYRAZINE DERIVATIVES USEFUL AS HERBICIDAL COMPOUNDS The present invention relates to novel, herbicidal 5-haloalkyl-5H-pyrido[2,3 b]pyrazin-6-ones and 5-haloalkenyl-5H-pyrido[2,3-b]pyrazin-6-ones, to processes for 5 their preparation, to compositions comprising those compounds, and to their use in controlling plants or in inhibiting plant growth. Pyrido[2,3-b]pyrazines were disclosed as intermediates in the synthesis of fungicidal compounds, for example, in WO 04/056825, WO 05/123698 and WO 05/123733. Pyrido[2,3-b]pyrazines were disclosed as fungicidal compounds in 10 WO 05/010000. It has now surprisingly been found that certain 5-haloalkyl-5H-pyrido[2,3 b]pyrazin-6-ones and 5-haloalkenyl-5H-pyrido[2,3-b]pyrazin-6-ones display excellent herbicidal and growth-inhibiting properties. The present invention therefore provides a compound of formula (I) R 2(I R N N 0 15 R wherein R' and R 2 are independently hydrogen, C-C 4 alkyl, C-C 4 haloalkyl, halo, cyano, hydroxy, C-C 4 alkoxy, CI-C 4 alkylthio, aryl or aryl substituted by one to five R , which 6 may be the same or different, or heteroaryl or heteroaryl substituted by one to five R, 20 which may be the same or different;
R
3 is C 1
-C
4 haloalkyl, C 2
-C
4 haloalkenyl or C 2
-C
4 haloalkynyl;
R
4 is aryl or aryl substituted by one to five R 8 , which may be the same or different, or heteroaryl or heteroaryl substituted by one to four R 8 , which may be the same or different; 25 R 5 is hydroxy or a group which can be metabolised to the hydroxy group; each R 6 and R 8 is independently halo, cyano, nitro, CI-Cioalkyl, C 1
-C
4 haloalkyl, C 2 Cioalkenyl, C 2 -Cloalkynyl, hydroxy, C 1 -Cioalkoxy, C 1
-C
4 haloalkoxy, C 1 -Cioalkoxy-C 1 C 4 alkyl-, C 3
-C
7 cycloalkyl, C 3
-C
7 cycloalkoxy, C 3
-C
7 cycloalkyl-C-C 4 alkyl-, C 3 C 7 cycloalkyl-C-C 4 alkoxy-, CI-C 6 alkylcarbonyl-, formyl, C-C 4 alkoxycarbonyl-, C 1 30 C 4 alkylcarbonyloxy-, C-Cloalkylthio-, C 1
-C
4 haloalkylthio-, C-C 10 alkylsulfinyl-, C 1
-
WO 2008/071918 PCT/GB2007/004662
C
4 haloalkylsulfinyl-, C 1
-C
1 oalkylsulfonyl-, C 1
-C
4 haloalkylsulfonyl-, amino, C 1 C 10 alkylamino-, di-C 1 -Cioalkylamino-, Ci-C 10 alkylcarbonylamino-, aryl or aryl substituted by one to three R1 3 , which may be the same or different, heteroaryl or heteroaryl substituted by one to three R 1 3 , which may be the same or different, aryl-C 13 5 C 4 alkyl- or aryl-C 1
-C
4 alkyl- wherein the aryl moiety is substituted by one to three R which may be the same or different, heteroaryl-C-C 4 alkyl- or heteroaryl-C-C 4 alkyl wherein the heteroaryl moiety is substituted by one to three R', which may be the same or different, aryloxy- or aryloxy- substituted by one to three R 13 , which may be the same or different, heteroaryloxy- or heteroaryloxy- substituted by one to three R , which may 10 be the same or different, arylthio- or arylthio- substituted by one to three R 13 , which may be the same or different, or heteroarylthio- or heteroarylthio- substituted by one to three R1 3 , which may be the same or different; and 13 each R is independently halo, cyano, nitro, CI-C 6 alkyl, C-C 6 haloalkyl or C-C 6 alkoxy; or a salt or N-oxide thereof. 15 The compounds of formula (I) may exist in different geometric or optical isomers or tautomeric forms. This invention covers all such isomers and tautomers and mixtures thereof in all proportions as well as isotopic forms such as deuterated compounds. For example, a compound of formula (Ia), i.e. a compound of formula (I) wherein
R
5 is as defined for compounds of formula (I) other than hydroxy, can be drawn in only 20 one tautomeric form.
R
5 R 1 N R 4 2 R N N 0 13 R (1a) Whereas a compound of formula (Ib), i.e. a compound of formula (I) wherein R 5 is hydroxy, can be drawn in three tautomeric forms. OH 0 0 R N R 1 R N R N4 222 R N N 0 R N N O R N N 01 13 13 13 R R R (Ib) 25 WO 2008/071918 PCT/GB2007/004662 Each alkyl moiety (either alone or as part of a larger group, such as alkoxy, alkoxycarbonyl, alkylcarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl) is a straight or branched chain and is, for example, methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, iso-propyl, n-butyl, sec-butyl, iso-butyl, tert-butyl or neo-pentyl. The alkyl groups are 5 preferably C 1
-C
6 alkyl groups, more preferably CI-C 4 and most preferably CI-C 3 alkyl groups. Alkenyl and alkynyl moieties (either alone or as part of a larger group, such as alkenyloxy or alkynyloxy) can be in the fonn of straight or branched chains, and the alkenyl moieties, where appropriate, can be of either the (E)- or (Z)-configuration. 10 Examples are vinyl, allyl, prop-2-enyl and propargyl. The alkenyl and alkynyl groups are preferably C 2
-C
6 alkenyl or alkynyl groups, more preferably C 2
-C
4 and most preferably
C
2
-C
3 alkenyl or alkynyl groups. Halogen is fluorine, chlorine, bromine or iodine. Haloalkyl groups (either alone or as part of a larger group, such as haloalkoxy or 15 haloalkylthio) are alkyl groups which are substituted with one or more of the same or different halogen atoms and are, for example, -CF 3 , -CF 2 CL, -CHF 2 , -CH 2
CF
3 or
-CH
2
CHF
2 . Haloalkenyl and haloalkynyl groups (either alone or as part of a larger group, such as haloalkenyloxy or haloalkynyloxy) are alkenyl and alkynyl groups, respectively, which are substituted with one or more of the same or different halogen atoms and are, 20 for example, -CH=CF 2 , -CCl=CClF or -C=CCl. Cycloalkyl groups can be in mono- or bi-cyclic form and may optionally be substituted by one or more methyl groups. The cycloalkyl groups preferably contain 3 to 8 carbon atoms, more preferably 3 to 6 carbon atoms. Examples of monocyclic cycloalkyl groups are cyclopropyl, 1-methylcyclopropyl, 2-methylcyclopropyl, 25 cyclobutyl, cyclopentyl and cyclohexyl. In the context of the present specification the tenn "aryl" refers to a ring system which may be mono-, bi- or tricyclic. Examples of such rings include phenyl, naphthalenyl, anthracenyl, indenyl or phenanthrenyl. A preferred aryl group is phenyl. The term "heteroaryl" refers to an aromatic ring system containing at least one 30 heteroatom and consisting either of a single ring or of two or more fused rings. Preferably, single rings will contain up to three and bicyclic systems up to four heteroatoms which will preferably be chosen from nitrogen, oxygen and sulfur. Examples of such groups include pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, furanyl, thiophenyl, oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, isothiazolyl, thiadiazolyl, WO 2008/071918 PCT/GB2007/004662 pyrrolyl, pyrazolyl, imidazolyl, triazolyl and tetrazolyl. A preferred heteroaryl group is pyridine. Examples of bicyclic groups are benzothiophenyl, benzimidazolyl, benzothiadiazolyl, quinolinyl, cinnolinyl, quinoxalinyl and pyrazolo[1,5-a]pyrimidinyl. The term "heterocyclyl" is defined to include heteroaryl and in addition their 5 unsaturated or partially unsaturated analogues such as 4,5,6,7-tetrahydro benzothiophenyl, chromen-4-onyl, 9H-fluorenyl, 3,4-dihydro-2H-benzo-1,4-dioxepinyl, 2,3-dihydro-benzofuranyl, piperidinyl, 1,3-dioxolanyl, 1,3-dioxanyl, 4,5-dihydro isoxazolyl, tetrahydrofuranyl and morpholinyl. The term "herbicide" as used herein means a compound that controls or modifies 10 the growth of plants. The term "herbicidally effective amount" means the quantity of such a compound or combination of such compounds that is capable of producing a controlling or modifying effect on the growth of plants. Controlling or modifying effects include all deviation from natural development, for example: killing, retardation, leaf burn, albinism, dwarfing and the like. The term "plants" refers to all physical parts of a 15 plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, foliage, and fruits. The term "locus" is intended to include soil, seeds, and seedlings, as well as established vegetation. The term "metabolism" as used herein means the conversion or breakdown of a substance from one form to another by a living organism, in particular in a plant (in planta). 5 103 11 12 20 Preferred values of R1, R, R3,R , R ', R 6 , R ', R 9 , R', R , R , R 1 3 and R 1 4 are, in any combination, as set out below. Preferably R 1 is hydrogen, C 1
-C
4 alkyl, C 1
-C
4 haloalkyl, halo, cyano, hydroxy or
C
1
-C
4 alkoxy. More preferably R 1 is hydrogen, C 1
-C
4 alkyl, halo, cyano or hydroxy. 25 Even more preferably R 1 is hydrogen, methyl, chloro or bromo. Yet even more preferably R 1 is hydrogen or chloro. Most preferably R' is hydrogen. Preferably R2 is hydrogen, CI-C 4 alkyl, C 1
-C
4 haloalkyl, halo, cyano, hydroxy or
C
1
-C
4 alkoxy. 30 More preferably R2 is hydrogen, C 1
-C
4 alkyl, halo, cyano or hydroxy. Even more preferably R2 is hydrogen, methyl, chloro or bromo. Yet even more preferably R 2 is hydrogen or chloro. Most preferably R 2 is hydrogen.
WO 2008/071918 PCT/GB2007/004662 Preferably R 3 is C1-C 4 haloalkyl or C 2
-C
4 haloalkenyl. Examples of such preferred groups for R 3 are 2-fluoro-ethyl, 2,2-difluoro-ethyl, 2,2,2-trifluoro-ethyl, 3-chloro propyl, 3,3,3-trifluoro-propyl, 4-chloro-butyl, 4,4,4,3,3-pentafluoro-butyl, 2-chloro-prop 2-en-1-yl, 3,3-dichloro-prop-2-en-1-yl, 2-fluoro-prop-2-en-1-yl, 3,3-difluoro-prop-2-en 5 1-yl, 4,4-difluoro-but-3-en-1-yl and 3,4,4-trifluoro-but-3-en-1-yl. More preferably R 3 is C 1
-C
3 haloalkyl, in particular where the halogen atoms are fluorine. Examples of such more preferred groups for R 3 are 2-fluoro-ethyl, 2,2-difluoro ethyl, 2,2,2-trifluoro-ethyl and 3,3,3-trifluoro-propyl. Even more preferably R 3 is C 1
-C
2 haloalkyl, in particular where the halogen atoms 10 are fluorine. Examples of such even more preferred groups for R3 are 2-fluoro-ethyl, 2,2 difluoro-ethyl and 2,2,2-trifluoro-ethyl. Most preferably R3 is 2,2-difluoro-ethyl. Preferably R 4 is aryl or aryl substituted by one to five R , which may be the same or different. Examples of such preferred groups for R4 are 2,5-bis-(trifluoromethyl) 15 phenyl, 3-bromo-2-chloro-6-fluoro-phenyl, 2-bromo-4-fluoro-phenyl, 5-bromo-2 methoxy-phenyl, 2-bromo-phenyl, 2-bromo-4-trifluoromethyl-phenyl, 2-chloro-3,6 difluoro-5-nitro-phenyl, 2-chloro-3,6-difluoro-phenyl, 2-chloro-4,5-difluoro-phenyl, 2 chloro-6-fluoro-3-methyl-phenyl, 2-chloro-6-fluoro-5-methyl-phenyl, 2-chloro-6-fluoro 3-nitro-phenyl, 2-chloro-4-fluoro-phenyl, 2-chloro-5-fluoro-phenyl, 2-chloro-6-fluoro 20 phenyl, 2-chloro-phenyl, 3-chloro-phenyl, 4-chloro-phenyl, 2-chloro-3-trifluoromethyl phenyl, 2-chloro-5-trifluoromethyl-phenyl, 5-chloro-2-trifluoromethyl-phenyl, 2-chloro 6-trifluoromethyl-phenyl, 2,3-dichloro-6-fluoro-phenyl, 2,4-dichloro-5-fluoro-phenyl, 3,5-dichloro-2-methoxy-phenyl, 2,3-dichloro-phenyl, 2,4-dichloro-phenyl, 2,5-dichloro phenyl, 2,6-dichloro-phenyl, 3,4-dichloro-phenyl, 2,6-dichloro-4-trifluoromethoxy 25 phenyl, 2,6-dichloro-4-trifluoromethyl-phenyl, 2,6-diethyl-4-methyl-phenyl, 2 difluoromethoxy-phenyl, 4,5-difluoro-2-methoxy-phenyl, 2,3-dimethoxy-phenyl, 2,4 dimethoxy-phenyl, 2,5-dimethyl-phenyl, 2-ethyl-phenyl, 2-fluoro-phenyl, 4-fluoro-2 trifluoromethyl-phenyl, 6-fluoro-2-trifluoromethyl-phenyl, 2-iodo-phenyl, 2-methoxy phenyl, 2-methoxy-5-trifluoromethoxy-phenyl, 6-methyl-2-nitro-phenyl, 2-methyl 30 phenyl, naphth-2-yl, naphth-3-yl, phenyl, 2-nitro-4-trifluoromethyl-phenyl, 2,3,5 trichloro-phenyl, 2,3,6-trichloro-phenyl, 2-trifluoromethoxy-phenyl, 2-trifluoromethyl phenyl, 2,3,6-trifluoro-phenyl and 2,4,6-trimethyl-phenyl. More preferably R4 is aryl substituted by one to four R8, which may be the same or different. Examples of such more preferred groups for R4 are 2,5-bis-(trifluoromethyl)- WO 2008/071918 PCT/GB2007/004662 phenyl, 3-bromo-2-chloro-6-fluoro-phenyl, 2-chloro-3,6-difluoro-phenyl, 2-chloro-4 fluoro-phenyl, 2-chloro-5-fluoro-phenyl, 2-chloro-phenyl, 2-chloro-3-trifluoromethyl phenyl, 2-chloro-5-trifluoromethyl-phenyl, 2-chloro-6-trifluoromethyl-phenyl, 2,3 dichloro-6-fluoro-phenyl, 2,4-dichloro-5-fluoro-phenyl, 3,5-dichloro-2-methoxy-phenyl, 5 2,3-dichloro-phenyl, 2,4-dichlioro-phenyl, 2,5-dichloro-phenyl, 2,6-dichloro-phenyl, 2,6 dichloro-4-trifluoromethoxy-phenyl, 2,6-dichloro-4-trifluoromethyl-phenyl, 2,6-diethyl 4-methyl-phenyl, 2,3-dimethoxy-phenyl, 2-fluoro-phenyl, 2-methoxy-phenyl, 2 methoxy-5-trifluoromethoxy-phenyl, 2,3,6-trichloro-phenyl, 2-trifluoromethoxy-phenyl, 2-trifluoromethyl-phenyl and 2,4,6-trimethyl-phenyl. 10 Most preferably R 4 is aryl substituted by two to three R 8 , which may be the same or different. Examples of such most preferred groups for R 4 are 2,5-bis-(trifluoromethyl) phenyl, 3-bromo-2-chloro-6-fluoro-phenyl, 2-chloro-3,6-difluoro-phenyl, 2-chloro-5 fluoro-phenyl, 2-chloro-5-trifluoromethyl-phenyl, 2-chloro-6-trifluoromethyl-phenyl, 2,3-dichloro-6-fluoro-phenyl, 2,6-dichloro-phenyl, 2,6-dichloro-4-trifluoromethoxy 15 phenyl and 2,3,6-trichloro-phenyl. In one preferred embodiment R4 is 2,5-bis-(trifluoromethyl)-phenyl. In one preferred embodiment R4 is 3-bromo-2-chloro-6-fluoro-phenyl. In one preferred embodiment R 4 is 2-chloro-3,6-difluoro-phenyl. In one preferred embodiment R4 is 2-chloro-5-fluoro-phenyl. 20 In one preferred embodiment R is 2-chloro-5-trifluoromethyl-phenyl. In one preferred embodiment R4 is 2-chloro-6-trifluoromethyl-phenyl. In one preferred embodiment R 4 is 2,3-dichloro-6-fluoro-phenyl. In one preferred embodiment R 4 is 2,6-dichloro-phenyl. In one preferred embodiment R 4 is 2,6-dichloro-4-trifluoromethoxy-phenyl. 25 In one preferred embodiment R 4 is 2,3,6-trichloro-phenyl. Preferably R5 is hydroxy, R 9 -oxy-, R' 0 -carbonyloxy-, tri-R 1 -silyloxy- or R1 sulfonyloxy-, wherein R9 is C 1 -Cioalkyl, C 2 -Cioalkenyl, C 2 -Cioalkynyl or aryl-Ci-C 4 alkyl- or aryl-C 1
-C
4 alkyl wherein the aryl moiety is substituted by one to five substituents independently selected 30 from halo, cyano, nitro, C 1
-C
6 alkyl, C 1
-C
6 haloalkyl or CI-C 6 alkoxy;
R'
0 is Ci-Cioalkyl, C 3 -Ciocycloalkyl, C 3 -Ciocycloalkyl-C1-Cioalkyl-, C 1 -Ciohaloalkyl, C 2 Cioalkenyl, C 2 -CiOalkynyl, C 1
-C
4 alkoxy-Ci-Cioalkyl-, C 1
-C
4 alkylthio-C 1
-C
4 alkyl-, C 1 Cioalkoxy, C 2 -Cioalkenyloxy, C 2 -Cioalkynyloxy, C 1 -Cioalkylthio-, N-C 1
-C
4 alkyl-amino-, N,N-di-(C1-C 4 alkyl)-amino-, aryl or aryl substituted by one to three R 14 , which may be WO 2008/071918 PCT/GB2007/004662 the same or different, heteroaryl or heteroaryl substituted by one to three R 1 4 , which may be the same or different, aryl-C1-C 4 alkyl- or aryl-C1-C 4 alkyl- wherein the aryl moiety is substituted by one to three R1 4 , which may be the same or different, heteroaryl-C1
C
4 alkyl- or heteroaryl-C 1
-C
4 alkyl- wherein the heteroaryl moiety is substituted by one to 5 three R 1 4 , which may be the same or different, aryloxy- or aryloxy- substituted by one to three R 1 4 , which may be the same or different, heteroaryloxy- or heteroaryloxy substituted by one to three R 1 4 , which may be the same or different, arylthio- or arylthio substituted by one to three R 1 4 , which may be the same or different, or heteroarylthio- or heteroarylthio- substituted by one to three R 4 , which may be the same or different; 10 each R 11 is independently C 1 -Cioalkyl or phenyl or phenyl substituted by one to five substituents independently selected from halo, cyano, nitro, C 1
-C
6 alkyl, C 1
-C
6 haloalkyl or C 1
-C
6 alkoxy;
R
1 2 is C1-Cioalkyl, Ci-Ciohaloalkyl, or phenyl or phenyl substituted by one to five substituents independently selected from halo, cyano, nitro, C 1
-C
6 alkyl, Ci-C 6 haloalkyl 15 or CI-C 6 alkoxy; and each R 1 4 is independently halo, cyano, nitro, C1-Cioalkyl, C 1
-C
4 haloalkyl, C1-Cioalkoxy,
C
1
-C
4 alkoxycarbonyl-, C 1
-C
4 haloalkoxy, C 1 -Cioalkylthio-, C 1
-C
4 haloalkylthio-, C 1 Cioalkylsulfinyl-, C 1
-C
4 haloalkylsulfinyl-, CI-C 1 oalkylsulfonyl-, C1-C 4 haloalkylsulfonyl-, aryl or aryl substituted by one to five substituents independently selected from halo, 20 cyano, nitro, Ci-C 6 alkyl, C 1
-C
6 haloalkyl or CI-C 6 alkoxy, or heteroaryl or heteroaryl substituted by one to four substituents independently selected from halo, cyano, nitro, C 1 C 6 alkyl, C 1
-C
6 haloalkyl or CI-C 6 alkoxy. More preferably R 5 is hydroxy, R 9 -oxy- or R 10 -carbonyloxy-. Even more preferably R5 is hydroxy, C 1
-C
4 alkoxy, C1-C 4 alkylcarbonyloxy-, C 3 25 C 6 cycloalkylcarbonyloxy-, C 3 -Ciocycloalkyl-Ci-Cioalkylcarbonyloxy-, C 1
-C
4 haloalkyl carbonyloxy-, C 2
-C
4 alkenylcarbonyloxy-, C 2
-C
4 alkynylcarbonyloxy-, C 1 -C4alkoxy-C 1 C 4 alkylcarbonyloxy-, C 1
-C
4 alkylthio-C1-C 4 alkylcarbonyloxy-, C 1
-C
4 alkoxycarbonyloxy-,
C
2
-C
4 alkenyloxycarbonyloxy-, C 2
-C
4 alkynyloxycarbonyloxy-, C 1
-C
4 alkylthiocarbonyl oxy-, N-C 1
-C
4 alkyl-aminocarbonyloxy-, NN-di-(C 1 -C4alkyl)-aminocarbonyloxy-, aryl 30 carbonyloxy- or arylcarbonyloxy- substituted by one to three R 4 , which may be the same or different, heteroarylcarbonyloxy- or heteroarylcarbonyloxy- substituted by one to three R 1 4 , which may be the same or different, aryl-Cl-C4alkylcarbonyloxy- or aryl-C 1 C 4 alkylcarbonyloxy- wherein the aryl moiety is substituted by one to three R 14 , which may be the same or different, heteroaryl-C1 -C 4 alkylcarbonyloxy- or heteroaryl-C 1
-
WO 2008/071918 PCT/GB2007/004662
C
4 alkylcarbonyloxy- wherein the heteroaryl moiety is substituted by one to three R 14 , which may be the same or different, aryloxycarbonyloxy- or aryloxycarbonyloxy substituted by one to three R 14 , which may be the same or different, heteroaryloxycarbonyloxy- or heteroaryloxycarbonyloxy- substituted by one to three R' 4 , 5 which may be the same or different, arylthiocarbonyloxy- or arylthiocarbonyloxy substituted by one to three R 14, which may be the same or different, or heteroarylthio carbonyloxy- or heteroarylthiocarbonyloxy- substituted by one to three R1 4 , which may be the same or different. Examples of preferred groups for R 5 are hydroxy, methoxy, ethoxy, methylcarbonyloxy-, ethylcarbonyloxy-, iso-propylcarbonyloxy-, n-propyl 10 carbonyloxy-, but-2-ylcarbonyloxy-, 2-methyl-propylcarbonyloxy-, tert-butylcarbonyl oxy-, cyclopropylcarbonyloxy-, cyclopentyl-methylcarbonyloxy-, chloromethylcarbonyl oxy-, trifluoromethylcarbonyloxy-, allylcarbonyloxy-, (E)-prop- 1-en-1 -ylcarbonyloxy-, 2-methyl-prop- 1-en-i -ylcarbonyloxy-, methoxymethylcarbonyloxy-, ethoxycarbonyloxy , tert-butoxycarbonyloxy-, but-2-yn-1-yloxycarbonyloxy-, ethylthiocarbonyloxy-, NN 15 diethylaminocarbonyloxy-, phenylcarbonyloxy-, 3-methoxy-phenylcarbonyloxy-, 4 nitro-phenylcarbonyloxy-, benzylcarbonyloxy-, furan-2-ylcarbonyloxy-, 2,5-dimethyl furan-3-ylcarbonyloxy-, thiophen-2-ylcarbonyloxy-, 3,5-dimethyl-isoxazol-4-ylcarbonyl oxy-, and 1-phenyl-prop-1-ylcarbonyloxy-. Yet even more preferably R 5 is hydroxy, C 1
-C
4 alkylcarbonyloxy-, C 3
-C
6 cyclo 20 alkylcarbonyloxy-, C 2
-C
4 alkenylcarbonyloxy-, C 2
-C
4 alkynylcarbonyloxy-, C 1
-C
4 alkoxy carbonyloxy-, C 2
-C
4 alkenyloxycarbonyloxy-, C 2
-C
4 alkynyloxycarbonyloxy- or C1
C
4 alkylthiocarbonyloxy-. Examples of more preferred groups for R 5 are hydroxy, methylcarbonyloxy-, ethylcarbonyloxy-, iso-propylcarbonyloxy-, n-propylcarbonyloxy-, but-2-ylcarbonyloxy-, 2-methyl-propylcarbonyloxy-, tert-butylcarbonyloxy-, cyclo 25 propylcarbonyloxy-, allylcarbonyloxy-, (E)-prop- 1-en-1 -ylcarbonyloxy-, 2-methyl-prop 1-en-i -ylcarbonyloxy-, ethoxycarbonyloxy-, tert-butoxycarbonyloxy-, but-2-yn- 1 -yloxy carbonyloxy-, and ethylthiocarbonyloxy-. Most preferably R 5 is hydroxy, C 1
-C
4 alkylcarbonyloxy-, CI-C 4 alkoxycarbonyl oxy- or C 1
-C
4 alkylthiocarbonyloxy-. Examples of most preferred groups for R 5 are 30 hydroxy, methylcarbonyloxy-, ethylcarbonyloxy-, iso-propylcarbonyloxy-, n-propyl carbonyloxy-, but-2-ylcarbonyloxy-, 2-methyl-propylcarbonyloxy-, tert-butylcarbonyl oxy-, ethoxycarbonyloxy-, tert-butoxycarbonyloxy-, and ethylthiocarbonyloxy-. In one preferred embodiment R 5 is hydroxy.
WO 2008/071918 PCT/GB2007/004662 In one preferred embodiment R 5 is R 9 -oxy-, wherein R 9 is C 1 -C1oalkyl, C 2 C1oalkenyl, C 2 -Cioalkynyl or aryl-Ci-C 4 alkyl- or aryl-C 1
-C
4 alkyl- wherein the aryl moiety is substituted by one to five substituents independently selected from halo, cyano, nitro, C1-C 6 alkyl, C1-C 6 haloalkyl or C 1
-C
6 alkoxy. Such R 5 groups may be metabolised, 5 preferably in planta, to give the corresponding compound wherein R5 is hydroxy. In one preferred embodiment Rs is R 10 -carbonyloxy-, wherein R1 0 is C 1 -Cioalkyl,
C
3 -Ciocycloalkyl, C 3 -Ciocycloalkyl-C1-Cioalkyl-, C 1 -Ciohaloalkyl, C 2 -Cioalkenyl, C 2 Cioalkynyl, C 1
-C
4 alkoxy-Ci-Cioalkyl-, C 1
-C
4 alkylthio-CI-C 4 alkyl-, C 1
-C
1 oalkoxy, C 2 C1oalkenyloxy, C 2 -Cioalkynyloxy, C 1
-C
1 oalkylthio-, N-C 1
-C
4 alkyl-amino-, NN-di-(C1 14 10 C 4 alkyl)-amino-, aryl or aryl substituted by one to three R , which may be the same or different, heteroaryl or heteroaryl substituted by one to three R 4 , which may be the same or different, aryl-C 1
-C
4 alkyl- or aryl-C1-C 4 alkyl- wherein the aryl moiety is substituted by one to three R1 4 , which may be the same or different, heteroaryl-C1-C 4 alkyl- or heteroaryl-C 1
-C
4 alkyl- wherein the heteroaryl moiety is substituted by one to three R14, 14 15 which may be the same or different, aryloxy- or aryloxy- substituted by one to three R which may be the same or different, heteroaryloxy- or heteroaryloxy- substituted by one to three R 1 4 , which may be the same or different, arylthio- or arylthio- substituted by one to three R 1 4 , which may be the same or different, or heteroarylthio- or heteroarylthio substituted by one to three R1 4 , which may be the same or different; and each R 1 4 is 20 independently halo, cyano, nitro, C1-Cioalkyl, Ci-C 4 haloalkyl, C1-Cioalkoxy, C1
C
4 alkoxycarbonyl-, C 1
-C
4 haloalkoxy, C 1 -Cioalkylthio-, C 1
-C
4 haloalkylthio-, C 1 C1oalkylsulfinyl-, C 1
-C
4 haloalkylsulfinyl-, C1-C1oalkylsulfonyl-, Ci-C 4 haloalkylsulfonyl-, aryl or aryl substituted by one to five substituents independently selected from halo, cyano, nitro, C 1
-C
6 alkyl, C 1
-C
6 haloalkyl or C1-C 6 alkoxy, or heteroaryl or heteroaryl 25 substituted by one to four substituents independently selected from halo, cyano, nitro, C 1 C 6 alkyl, C1-C 6 haloalkyl or C 1
-C
6 alkoxy. Such R 5 groups may be metabolised, preferably in planta, to give the corresponding compound wherein R5 is hydroxy. In one preferred embodiment R 5 is iso-propylcarbonyloxy- or tert-butyl carbonyloxy-. 30 In one preferred embodiment R 5 is Ci-C 4 alkylsulfonyloxy-. Examples of such preferred groups for R 5 are methylsulfonyloxy- and iso-propylsulfonyloxy-. In one preferred embodiment R5 is tri-(Ci-C 4 alkyl)-silyloxy-. An example of a preferred group for R 5 is dimethyl-tert-butyl-silyloxy-.
WO 2008/071918 PCT/GB2007/004662 Preferably each R 6 is independently halo, CI-C 4 alkyl, CI-C 4 haloalkyl, C 1 C 4 alkoxy or C 1
-C
4 haloalkoxy. Examples of such preferred groups for R 6 are chloro, fluoro, methyl, ethyl, trifluoromethyl, methoxy or trifluoromethoxy. Preferably each R 8 is independently halo, cyano, nitro, C1-Cioalkyl, C 1 5 C 4 haloalkyl, C1-Cioalkoxy, C 1
-C
4 alkoxycarbonyl-, C 1
-C
4 haloalkoxy, C 1 -Cioalkylthio-,
C
1
-C
4 haloalkylthio-, Ci-Cioalkylsulfinyl-, C 1
-C
4 haloalkylsulfinyl-, C 1 -Cioalkylsulfonyl or C 1
-C
4 haloalkylsulfonyl-. More preferably each R 8 is independently halo, cyano, nitro, C1-Cioalkyl, C 1 C 4 haloalkyl, C 1 -Cioalkoxy, C 1
-C
4 alkoxycarbonyl-, C 1
-C
4 haloalkoxy, C 1 -C1oalkylthio or 10 CI-C 4 haloalkylthio. Examples of such more preferred groups for R8 are iodo, bromo, chloro, fluoro, cyano, nitro, methyl, ethyl, trifluoromethyl, methoxy, methoxycarbonyl, trifluoromethoxy or trifluoromethylthio. Most preferably each R 8 is independently halo, C1-Cioalkyl, C 1
-C
4 haloalkyl, C 1 Cioalkoxy or C 1
-C
4 haloalkoxy. Examples of such most preferred groups for R 8 are 15 bromo, chloro, fluoro, methyl, ethyl, trifluoromethyl, methoxy or trifluoromethoxy. In one embodiment, R 9 is preferably C1-Cioalkyl, more preferably CI-C 4 alkyl, even more preferably methyl or ethyl, most preferably methyl. In another embodiment, R 9 is preferably C 2 -Cioalkenyl, C 2 -Cioalkynyl, aryl-C1 13
C
4 alkyl- or aryl-C1-C 4 alkyl- wherein the aryl moiety is substituted by one to three R 20 which may be the same or different, more preferably C 3
-C
4 alkenyl, or C 3
-C
4 alkynyl, benzyl or benzyl wherein the phenyl moiety is substituted by one to three R', which may be the same or different, even more preferably allyl, propargyl or benzyl, most preferably
R
9 is allyl. Preferably R 1 0 is C 1 -Cioalkyl, C 3 -Ciocycloalkyl, C 1 -Ciohaloalkyl, C 2 -Cioalkenyl, 25 C 2 -Cioalkynyl, C 1
-C
4 alkoxy-C1-Cioalkyl-, C1-C 4 alkylthio-C1-C 4 alkyl-, C 1
-C
1 oalkoxy, C1 Cioalkylthio-, N-C 1
-C
4 alkyl-amino-, NN-di-(C 1
-C
4 alkyl)-amino-, phenyl or phenyl substituted by one to three R 1 4 , which may be the same or different, benzyl or benzyl wherein the phenyl moiety is substituted by one to three R1 4 , which may be the same or different, thienyl or thienyl substituted by one to three R 1 4 , which may be the same or 30 different, pyridyl or pyridyl substituted by one to three R1 4 , which may be the same or different, phenoxy or phenoxy substituted by one to three R1 4 , which may be the same or different, or phenylthio or phenylthio substituted by one to three R 14 , which may be the same or different. Most preferably R 10 is iso-propyl or tert-butyl.
WO 2008/071918 PCT/GB2007/004662 Preferably each R 11 is independently CI-C 4 alkyl. Preferably R 12 is C 1
-C
4 alkyl or CI-C 4 haloalkyl. Preferably each R1 3 is independently halo, nitro, C 1
-C
4 alkyl, C1-C 4 haloalkyl or
C
1
-C
4 alkoxy. Examples of such preferred groups are chloro, fluoro, nitro, methyl, ethyl, 5 trifluoromethyl and methoxy. Preferably each R 1 4 is independently halo, nitro, C 1
-C
4 alkyl, C 1
-C
4 haloalkyl, CI
C
4 alkoxy or C1-C 4 haloalkoxy. Examples of such preferred groups are chloro, fluoro, nitro, methyl, ethyl, trifluoromethyl, methoxy and trifluoromethoxy. More preferably each R 1 4 is independently halo, C 1
-C
4 alkyl, C 1
-C
4 haloalkyl or 10 C 1
-C
4 alkoxy. The compounds in Tables 1 to 27 below illustrate the compounds of the invention. 15 Table 1: Table 1 provides 30 compounds of formula (I), where Ri 1 and R 2 are both hydrogen, R 4 is 2-chloro-3,6-difluoro-phenyl and R 3 and R 5 have the values listed in Table 1. R 5 R 2 N N 0 13 R Compound R 3 R Compound R3 R5 number number 1.001 2,2- -OH 1.006 2,2- -OCOC(C difluoro- difluoro- H 3
)
3 ethyl ethyl 1.002 2,2- -OCH 3 1.007 2,2- -OCO difluoro- difluoro- cyclo ethyl ethyl C 3
H
5 1.003 2,2- -OCOCH 3 1.008 2,2- -OCO difluoro- difluoro- C 6
H
5 ethyl ethyl 1.004 2,2- -OCOCH 2 1.009 2,2- -OCOCH 2 difluoro- CH 3 difluoro- C 6
H
5 ethyl ethyl 1.005 2,2- -OCOCH( 1.010 2,2- -OCOCH 2 difluoro- CH 3
)
2 difluoro- Cl ethyl ethyl WO 2008/071918 PCT/GB2007/004662 Compound R 3
R
5 Compound R 3 R5 number number 1.011 2,2- -OCOCF 3 1.021 2,2,2- -OCOC(C difluoro- trifluoro- H 3
)
3 ethyl ethyl 1.012 2,2- -OCOCH 2 1.022 2,2,2- -OCO difluoro- OCH 3 trifluoro- cyclo ethyl ethyl C 3
H
5 1.013 2,2- -OCON(C 1.023 2,2,2- -OCO difluoro- H 3
CH
2
)
2 trifluoro- C 6
H
5 ethyl ethyl 1.014 2,2- -O(CO)O 1.024 2,2,2- -OCOCH 2 difluoro- CH 2
CH
3 trifluoro- C 6
H
5 ethyl ethyl 1.015 2,2- -O(CO)SC 1.025 2,2,2- -OCOCH 2 difluoro- H 2
CH
3 trifluoro- Cl ethyl ethyl 1.016 2,2,2- -OH 1.026 2,2,2- -OCOCF 3 trifluoro- trifluoro ethyl ethyl 1.017 2,2,2- -OCH 3 1.027 2,2,2- -OCOCH 2 trifluoro- trifluoro- OCH 3 ethyl ethyl 1.018 2,2,2- -OCOCH 3 1.028 2,2,2- -OCON(C trifluoro- trifluoro- H 3
CH
2
)
2 ethyl ethyl 1.019 2,2,2- -OCOCH 2 1.029 2,2,2- -O(CO)O trifluoro- CH 3 trifluoro- CH 2
CH
3 ethyl ethyl 1.020 2,2,2- -OCOCH( 1.030 2,2,2- -O(CO)SC trifluoro- CH 3
)
2 trifluoro- H 2
CH
3 ethyl ethyl Table 2: Table 2 provides 30 compounds of formula (I), where R 1 and R 2 are both hydrogen, R 4 is 2-chloro-4-fluoro-phenyl and R3 and R 5 have the values listed in Table 1. 5 Table 3: Table 3 provides 30 compounds of fonnula (I), where R' and R2 are both hydrogen, R 4 is 2-chloro-phenyl and R 3 and R5 have the values listed in Table 1. Table 4: Table 4 provides 30 compounds of formula (I), where R' and R 2 are both hydrogen, R 4 is 10 3,5-dichloro-2-methoxy-phenyl and R 3 and R5 have the values listed in Table 1. Table 5: Table 5 provides 30 compounds of formula (I), where R 1 and R 2 are both hydrogen, R 4 is WO 2008/071918 PCT/GB2007/004662 2,3-dichloro-phenyl and R 3 and R 5 have the values listed in Table 1. Table 6: Table 6 provides 30 compounds of formula (I), where R 1 and R 2 are both hydrogen, R 4 is 2,4-dichloro-phenyl and R and R 5 have the values listed in Table 1. 5 Table 7: Table 7 provides 30 compounds of formula (I), where R 1 and R 2 are both hydrogen, R 4 is 2,5-dichloro-phenyl and R 3 and R 5 have the values listed in Table 1. Table 8: Table 8 provides 30 compounds of formula (I), where R 1 and R 2 are both hydrogen, R 4 is 10 2,6-dichloro-phenyl and R' and R 5 have the values listed in Table 1. Table 9: Table 9 provides 30 compounds of formula (I), where R' and R2 are both hydrogen, R 4 is 2,6-dichloro-4-trifluoromethyl-phenyl and R3 and R5 have the values listed in Table 1. Table 10: 15 Table 10 provides 30 compounds of formula (I), where R' and R2 are both hydrogen, R 4 is 2,6-diethyl-4-methyl-phenyl and R3 and R5 have the values listed in Table 1. Table 11: Table 11 provides 30 compounds of fonnula (I), where R 1 and R2 are both hydrogen, R 4 is 2-fluoro-phenyl and R 3 and R5 have the values listed in Table 1. 20 Table 12: Table 12 provides 30 compounds of formula (I), where R 1 and R2 are both hydrogen, R 4 is 2-methoxy-phenyl and R3 and R5 have the values listed in Table 1. Table 13: Table 13 provides 30 compounds of formula (I), where R' and R 2 are both hydrogen, R 4 25 is 2-trifluoromethoxy-phenyl and R3 and R' have the values listed in Table 1. Table 14: Table 14 provides 30 compounds of formula (I), where Ri and R2 are both hydrogen, R 4 is 2-trifluoromethyl-phenyl and R 3 and R5 have the values listed in Table 1. Table 15: 30 Table 15 provides 30 compounds of formula (I), where R 1 and R2 are both hydrogen, R4 is 3-bromo-2-chloro-6-fluoro-phenyl and R 3 and R5 have the values listed in Table 1. Table 16: Table 16 provides 30 compounds of fonnula (I), where R' and R2 are both hydrogen, R 4 is 2,3-dichloro-6-fluoro-phenyl and R 3 and R5 have the values listed in Table 1.
WO 2008/071918 PCT/GB2007/004662 Table 17: Table 17 provides 30 compounds of formula (I), where R 1 and R 2 are both hydrogen, R 4 is 2,6-dichloro-4-trifluoromethoxy-phenyl and R 3 and R' have the values listed in Table 1. 5 Table 18: Table 18 provides 30 compounds of formula (I), where R 1 and R 2 are both hydrogen, R 4 is 2-chloro-6-trifluoromethyl-pheny and R 3 and R' have the values listed in Table 1. Table 19: Table 19 provides 30 compounds of formula (I), where R' and R 2 are both hydrogen, R 4 10 is 2-chloro-5-trifluoromethyl-pheny and R 3 and R 5 have the values listed in Table 1. Table 20: Table 20 provides 30 compounds of formula (I), where R' and R 2 are both hydrogen, R 4 is 2-chloro-5-fluoro-phenyl and R 3 and R 5 have the values listed in Table 1. Table 21: 15 Table 21 provides 30 compounds of formula (I), where R 1 and R 2 are both hydrogen, R 4 is 2,4-dichloro-5-fluoro-phenyl and R 3 and R 5 have the values listed in Table 1. Table 22: Table 22 provides 30 compounds of formula (I), where R' and R 2 are both hydrogen, R 4 is 2-methoxy-5-trifluoromethoxy-pheny and R 3 and R 5 have the values listed in Table 1. 20 Table 23: Table 23 provides 30 compounds of formula (I), where R' and R2 are both hydrogen, R 4 is 2,3-dimethoxy-phenyl and R 3 and R 5 have the values listed in Table 1. Table 24: Table 24 provides 30 compounds of formula (I), where R and R2 are both hydrogen, R 4 25 is 2-chloro-3-trifluoromethyl-pheny and R3 and R5 have the values listed in Table 1. Table 25: Table 25 provides 30 compounds of formula (I), where R 1 and R 2 are both hydrogen, R 4 is 2,4,6-trimethyl-phenyl and R3 and R 5 have the values listed in Table 1. Table 26: 30 Table 26 provides 30 compounds of formula (I), where RI and R 2 are both hydrogen, R 4 is 2,5-bis-(trifluoromethyl)-phenyl and R 3 and R5 have the values listed in Table 1. Table 27: Table 27 provides 30 compounds of fonnula (I), where R' and R 2 are both hydrogen, R 4 is 2,3,6-trichloro-phenyl and R 3 and R 5 have the values listed in Table 1.
WO 2008/071918 PCT/GB2007/004662 The compounds of the invention may be made by a variety of methods, for example by the methods described in Schemes 1 to 14. 5 Scheme 1 R N COORi1 R4 X= CI, R N COOR 16 + base R NH2 X O X=OH, R2 NH amide R4 (2) (3) coupling (4) O method
R
1 0 base O O R 1 0 COCI OH R N R base, R NR 2X 2 A R N N 0 R N N 0 H H (6) (5) 1) Compounds of formula (4) wherein R1, R 2 and R 4 are as defined for a compound of formula (I) and Ri" is C 1
-C
6 alkyl can be made by reaction of an amino pyrazine ester of formula (2) wherein R 1 and R 2 are as defined for a compound of 10 formula (I) and R1 6 is CI-C 6 alkyl with an acid derivative of formula (3) wherein R 4 is as defined for a compound of formula (I) and X is halogen or hydroxy, as shown in Scheme 1. For example, if (3) is an acid chloride (i.e. where X is chlorine) the reaction can conveniently be carried out optionally in the presence of a base, such as triethylamine or pyridine, in a suitable solvent, such as acetonitrile or dichloromethane, optionally using 15 microwave heating. Alternatively, if (3) is a carboxylic acid (i.e. where X is hydroxy) the reaction can conveniently be carried out using an amide coupling method, for example by reaction with a coupling agent, such as bis(2-oxo-3-oxazolidinyl)phosphinic chloride, in the presence of a base, such as triethylamine, in a suitable solvent, such as dichloro methane, or other amide coupling methods which have been reviewed in Tetrahedron 20 (2005), 61(46), 10827-10852. 2) Compounds of formula (5) wherein R', R 2 and R 4 are as defined for a compound of formula (I) can be prepared by treating a compound of formula (4) as defined in 1) with a base in a suitable solvent, such as potassium carbonate in NN- WO 2008/071918 PCT/GB2007/004662 dimethylfonnamide or lithium hexamethyldisilazide in tetrahydrofuran, optionally using microwave heating. 3) Compounds of formula (6) wherein R', R 2 , R4 and R 10 are as defined for a compound of formula (I) can be prepared by reaction of a compound of formula (5) as 5 defined in 2) with an acid chloride of formula R 10 COCl or an acid anhydride of formula
(R
1
UCO)
2 0 wherein R1 0 is as defined for a compound of formula (I), optionally in the presence of a base, such as triethylamine or pyridine, optionally in a suitable solvent, such as dichloromethane. 10 Scheme 2 10
R
10 0 0 0 0 OJ OR 3 LG, 1 0 04 2 21N N R N N 0 H 13 (6). H20, base O'R" OH R 4
R
9 LG,
R
1 N 1<11 A . base ,, 2 - 2 R N N 0 R N N 0 13 13 (Ic) (Ib) 4) Compounds of formula (Id), i.e. a compound of formula (I) wherein R 5 is -0
CO-R
10 , can be prepared from a compound of formula (6) as defined in 3) by reaction with a compound of formula R 3 LG wherein R 3 is as defined for a compound of formula 15 (I) and LG is a leaving group such as a halide, for example bromide or iodide, or tosylate, mesylate or triflate, in the presence of a base, such as potassium carbonate, optionally in the presence of an activator / iodide, such as potassium iodide, in a suitable solvent, such as acetonitrile or NN-dimethylformamide, optionally using microwave heating, as shown in Scheme 2. 20 5) Compounds of formula (Ib), i.e. a compound of formula (I) wherein R 5 is hydroxy, can be prepared by treating a compound of fonnula (Id) as defined in 4) with a WO 2008/071918 PCT/GB2007/004662 base, such as sodium hydroxide or potassium carbonate, and water in a suitable solvent, such as methanol or NN-dimethylfonnamide. 6) Compounds of formula (Ic), i.e. a compound of formula (I) wherein R 5 is -0
R
9 , can be prepared from a compound of formula (Ib) as defined in 5) by reaction with a 5 compound of formula R 9 LG wherein R 9 is as defined for a compound of formula (I) and LG is a leaving group such as halide, for example bromide or iodide, or tosylate, mesylate or triflate, in the presence of a base, such as potassium carbonate, in a suitable solvent, such as NN-dimethylformamide. 10 Scheme 3 OH R N COOR 6 baseN R JN NH N2 O 4 (5) H (4) (1) R3LG, R 3 LG, base, (Method 1) (2) R10COCI, R3LG, base, base (Method 2) (one-pot reaction) base R OH O 0 R 10 COCI, R NR R N R 4 base R 2 N N 0 R 2 N N 0R3 3 (I b) (1d) R3LG, base, (Method 3) R N COOH 2 R N NH (4') WO 2008/071918 PCT/GB2007/004662 7) Compounds of formula (Id) as defined in 4) can additionally be prepared in a shortened route directly from a compound of fonnula (4) as defined in 1) by reaction with a compound of formula R 3 LG as defined in 4), in the presence of a base, such as sodium or potassium hexamethyldisilazide, in a suitable solvent, such as tetrahydrofuran, 5 optionally using microwave heating, followed by reaction with an acid chloride of formula R 1 UCOCl or an acid anhydride of formula (R 10
CO)
2 0 as defined in 3), optionally in the presence of a base, such as triethylamine, in the same reaction pot, as shown in Scheme 3. 8) Alternatively compounds of formula (Id) as defined in 4) can be made from a 10 compound of formula (Ib) as defined in 5), by reaction with an acid chloride of formula
R
10 COCl or an acid anhydride of formula (R1 0
CO)
2 0 as defined in 3), optionally in the presence of a base, such as triethylamine, optionally in a suitable solvent, such as dichloromethane. 9) Compounds of formula (Tb) as defined in 5) can be made by reaction of a 15 compound of formula (4) as defined in 1) with a compound of formula R 3 LG as defined in 4), in the presence of a base, such as potassium hexamethyldisilazide, in a suitable solvent, such as tetrahydrofuran, optionally using microwave heating (Method 1). 10) Compounds of formula (Ib) as defined in 5) can also be made from a compound of formula (5) as defined in 2) by reaction with a compound of formula R 3 LG 20 as defined in 4), in the presence of a base, such as potassium hexamethyldisilazide, in a suitable solvent, such as tetrahydrofuran, optionally using microwave heating (Method 2). The synthesis of compounds of formula (5) was described under 2). 11) Compounds of formula (Ib) as defined in 5) can also be made by reaction of a compound of fonnula (4') with a compound of formula R 3 LG as defined in 4), in the 25 presence of a base, such as sodium hexamethyldisilazide, in a suitable solvent, such as tetrahydrofuran, optionally using microwave heating (Method 3). Compounds of fonnula (4') can be made from a compound of formula (4) by reaction with a base, such as lithium hexamethyldisilazide, in a suitable solvent, such as tetrahydrofuran or NN-dimethyl fonnamide, optionally using microwave heating. 30 WO 2008/071918 PCT/GB2007/004662 Scheme 4 R OH (Rll) 3 SiCI, 0 R 11 R N R4 base N R N N 0 2: 13R N N 0 R 13 (Ib) (le) R 12) Silyl compounds of formula (Ie), i.e. a compound of formula (I) wherein R 5 is -O-Si(R 1)3, can be made from a compound of formula (Tb) as defined in 5), by reaction 5 with a trialkylsilyl chloride of formula (R" ') 3 SiC, in a suitable solvent, such as tetrahydrofuran or acetonitrile, in the presence of a base, such as triethylamine, as shown in Scheme 4. Scheme 5 R 1 2 -0 N R 0 2 Has R 1 N N R H H (5) (7)
R
3 LG, base R 1 OH S =O R N R4 R 1 2 S0 2 Cl, N R base R N N 0 R N N 13 N1 0 R R3 10 (Ib) (If) 13) Sulfonyl compounds of formula (7) wherein R 1 , R 2 , R 4 and R1 2 are as defined for a compound of formula (I) can be made from a compound of formula (5) as defined in 2) by reaction with a sulfonyl chloride of formula R 12SO 2 Cl wherein R1 2 is as defined for a compound of formula (I), in the presence of a base, such as triethylamine, in a 15 suitable solvent, such as tetrahydrofuran or dichloromethane, as shown in Scheme 5.
WO 2008/071918 PCT/GB2007/004662 14) Sulfonyl compounds of formula (If), i.e. a compound of formula (I) wherein R' is -0-S0 2 -R , can be made by reaction of a compound of formula (7) as defined in 13), with a compound of formula R 3 LG as defined in 4), in the presence of a base, such as sodium or potassium hexamethyldisilazide, in a suitable solvent, such as tetrahydro 5 furan, optionally using microwave heating. 15) Alternatively, compounds of formula (If) as defined in 14) can be made by reaction of a compound of formula (Ib) as defined in 5) with a sulfonyl chloride of formula R 12
SO
2 C1 as defined in 13), in the presence of a base, such as triethylamine, in a suitable solvent, such as tetrahydrofuran or dichloromethane. 10 Scheme 6 R10 R 1" "1,-"0 01_ 0 O O oxidising 1 + 4
R
4 agent R N R 2___R_ N. N 0 R N N 0 13N N 13 R (Id) (1g) 0 OH +1 NR4 2 R N N 0 [3 R (Ih) 16) A mixture of N-oxides of formula (Ig), i.e. a compound of formula (I) wherein the 5-nitrogen is oxidised, and R' is -0-CO-R, and N-oxides of formula (Ih), 15 i.e. a compound of formula (I) wherein the 5-nitrogen is oxidised, and R 5 is hydroxy, can be made by reaction of a compound of formula (Id) as defined in 4), with an oxidising agent, for example a per-acid, such as per-trifluoroacetic acid, generated in situ for example by trifluoroacetic anhydride and hydrogen peroxide on urea pellets, in a suitable solvent, such as dichloromethane, as shown in Scheme 6. 20 WO 2008/071918 PCT/GB2007/004662 Scheme 7
COOR
17 OH R1 N COOR 17 COOR 2 N NH base 2 S N NH R N N 0 2 H (2) (8) H20, acid OH 1 N Pb(OCOCH 3
)
3 OH R N Re (10) R R N 1 ) (10) base R 2 N N H H (11)(9) 17) Compounds of formula (8) wherein R' and R 2 are as defined for a compound of formula (I) and R 17 is CI-C 6 alkyl can be made by reaction of an aminopyrazine ester 5 of formula (2) as defined under 1) with a dialkyl malonate of formula CH 2
(CO
2
R)
2 wherein R 17 is CI-C 6 alkyl, in the presence of a base, such as sodium methoxide, in a suitable solvent, such as methanol, at a temperature of 20'C to reflux, preferably at reflux, as shown in Scheme 7. 18) Compounds of fonnula (9) wherein RI and R 2 are as defined for a compound 10 of formula (I) can be made by hydrolysis and decarboxylation of a compound of formula (8) as defined in 17) by treatment with strong aqueous acid, for example concentrated hydrochloric acid, or alternatively by treatment with dilute aqueous acid, for example dilute hydrochloric acid, and water in a suitable solvent, such as ethanol, optionally using microwave heating. 15 19) Compounds of formula (11) wherein R 1 , R 2 and R 8 are as defined for a compound of formula (I) can be made by reaction of a compound of formula (9) as defined in 18) with a lead compound of fonnula (10) wherein R8 is as defined for a compound of formula (I), in the presence of a base, such as 4-dimethylaminopyridine, and in a suitable solvent, such as dimethyl sulfoxide. Lead compounds (10) are known in 20 the literature and can be made by the methods as described in Aust. J. Chem., 1979, 32, 1561-6; and J. Chem. Soc. Perkin Trans. 1, 1990, 3, 715-20.
WO 2008/071918 PCT/GB2007/004662 Scheme 8 R 0 R 10 nitrating mixture 0 reduction 2 N e.g. HNO 3 , H 2
SO
4 R N NO 2 e.g. Fe, HCI R:: N N 0 2 r, R R N N 0 R 3 13 (12) (13) R R 108 10 O R R 17 -COCI or
R
8 O
(R
17
CO)
2 0, base 0 O
NH
2
N-COR
17 H R N N 0 R2 N N 3 R1 0 (14) R3 (15) R3 diazotisation e.g. HNO 2 , CuCN,
R
18 LG, base KCN 10 R" 10 O R R R O 0 1s 0 0
R
1 N R1 R N N-R1 R 1 118 R2 N N R N N 0 3 R3 (17) (16) 20) Nitro compounds of formula (13) wherein R', R 2 , R 3 , R' and R 10 are as 5 defined for a compound of fonnula (I), can be made by nitration of a compound of formula (12) wherein R 1 , R 2 , R3, R' and R 10 are as defined for a compound of formula (I), with a nitration mixture, for example fuming nitric acid and concentrated sulfuric acid, as shown in Scheme 8. 21) Amino compounds of fonnula (14) wherein R1, R2, R3, R' and R'0 are as 10 defined for a compound of formula (I), can be made by reduction of a compound of formula (13) as defined in 20), using standard reducing conditions, for example, iron filings in aqueous hydrochloric acid. 22) Acylated compounds of formula (15) wherein R1, R 2 , R 3 , R8 and Pi 0 are as defined for a compound of formula (I) and R1 7 is as defined in 17), can be made by 15 acylation of a compound of fonnula (14) as defined in 21), for example by reaction with an acid chloride of formula R 17 COCI or an acid anhydride (R1 7
CO)
2 0 wherein R 7 is as WO 2008/071918 PCT/GB2007/004662 defined in 17), in the presence of a base, such as triethylamine, in a suitable solvent, such as dichloromethane. 23) Alkylated compounds of formula (16) wherein R 1 , R 2 , R 3 , R' and R 1 0 are as defined for a compound of formula (I) and R 1 is C 1
-C
6 alkyl, can be made by alkylation 5 of a compound of formula (14) as defined in 21), for example by reaction with a compound of formula R' 8 LG, wherein R 18 is CI-C 6 alkyl and LG is a leaving group such as a halide, for example bromide or iodide, or tosylate, mesylate or triflate, optionally in the presence of a base, such as potassium carbonate, in a suitable solvent, such as ethanol or toluene. 10 24) Compounds of formula (17) wherein R 1 , R 2 , R 3 , R 8 and R' 0 are as defined for a compound of formula (I) and R19 is cyano, C 1
-C
4 alkylthio, halo, or hydroxy, can be made by reaction of a compound of formula (14) as defined in 21), by diazotisation, for example by reaction with an alkyl nitrite, in the presence of a suitable nucleophile, for example potassium cyanide, in the presence of a copper salt, for example cuprous 15 cyanide, in a suitable solvent, such as acetonitrile.
WO 2008/071918 PCT/GB2007/004662 Scheme 9
R
1 0 8 1 1 X 2 , light R N *7 R 1 N -1 R IN
CH
3 or NXS, radical RH N Xm R2 N N initiator, optional 2 13 light N N (18) R(19) R R 1
R
8 n=O, m=3 O O n=2, m=1 n=1, m=2 hydrolysis R N e.g. R 20 M, hydrolysis e.g. AgNO3, R170H
RHNR
20 base e.g. aq. H 2 SO4, or n=2, m=1 R2 N N 0 10 DMSO, base R R (20) R3 R 0 0 0
RR
1 N ' CHO 1 2 2 R N N 0 R N N 0 3
R
3 (22)
R
21 0-NH 2 .HCl, base e.g. NaOAc 1 R R 8 R8 O 0 dehydration O 0 e.g. Ac 2 O R 1 N R N N N0 R N 0 13 13 R R (24) (23) 25) Haloalkyl compounds of formula (19) wherein R', R 2 , R, R' and R 0 are as 5 defined for a compound of formula (I), X is a halogen and n+m =3, can be made by reaction of a compound of formula (18) with a halogenation agent, such as halogen of formula X 2 wherein X is chlorine or bromine, in the presence of light, or a N o N-X halosuccinimide of formula 0 wherein X is chlorine, bromine or iodine, in the presence of a radical initiator, such as benzoyl peroxide, in a suitable solvent, such as WO 2008/071918 PCT/GB2007/004662 carbon tetrachloride, and optionally in the presence of a light source, such as a 500 watt tungsten halogen lamp, at reflux, as shown in Scheme 9. 26) Compounds of formula (20) wherein R1, R2, R3, R and 1o are as defined for a compound of formula (I) and R 20 is CI-Csalkoxy, C-C 8 thioalkoxy, optionally 5 substituted phenoxy, optionally substituted thiophenoxy, cyano, hydroxy, CI -C 4 alkyl amino or di-(C-C 4 alkyl)amino, can be made by reaction of a compound of formula (19) as defined in 25) wherein n=2 and m=1, with a compound of formula R 20 H wherein R 20 is C-Csalkoxy, CI-C 8 thioalkoxy, optionally substituted phenoxy, optionally substituted thiophenoxy, a mono-(C-C 4 alkyl)amine or a di-(C-C 4 alkyl)amine, in the presence of a 10 base, such as potassium carbonate or sodium hydride, in a suitable solvent, such as ethanol or NN-dimethylformamide, or with a compound of formula R 20 M wherein R 20 is cyano and M is a metal, such as sodium, or wherein R 20 is hydroxy and M is a metal, such as sodium, in a suitable solvent, such as ethanol or NN-dimethylformamide. 27) Aldehydes of formula (21) wherein R 1 , R 2 , R 3 , R 8 and R 1 0 are as defined for a 15 compound of formula (I) can be made from a compound of formula (19) as defined in 25) where n=1 and m=2, by hydrolysis with an acid, for example aqueous sulfuric acid, or from a compound of formula (19) as defined in 25) where n=2 and m=1, by reaction with dimethylsulfoxide in the presence of a base, such as potassium carbonate. 28) Compounds of formula (22) wherein R1, R2, R3, R and R1 0 are as defined for 20 a compound of formula (I) and R 17 is as defined in 17), can be made from a compound of formula (19) as defined in 25) where n=0 and m=3, by hydrolysis with an alcohol of formula R 17 OH wherein R1 7 is as defined in 17), optionally in the presence of a silver salt, such as silver nitrate. 29) Compounds of formula (23) wherein R1, R2, R3, R and R 10 are as defined for 25 a compound of formula (I) and R 21 is CI-C 8 alkyl or optionally substituted benzyl can be made from an aldehyde of formula (21) as defined in 27) by reaction with a hydroxyl amine R O-NH 2 or its salt wherein R2 is C-C 8 alkyl or optionally substituted benzyl, for example the hydrochloride salt, optionally in the presence of a base, such as sodium acetate, in a suitable solvent, such as ethanol. 30 30) Compounds of fonnula (24) wherein R', R 2 , R3, R8, R1 0 are as defined for a compound of formula (I), can be made from a compound of fonnula (23) as defined in 29) in the particular case where R 21 is hydrogen, by reaction with a dehydrating agent, such as acetic anhydride.
WO 2008/071918 PCT/GB2007/004662 Scheme 10 Me X CN
X
2 or NXS MON R R R R8 solvent (25) (26) (27) acid or alkali COOH R8 (28) 31) In certain cases where aryl acetic acids are not commercially available it is necessary to make them. A typical synthesis is shown in Scheme 10. Benzyl halides of 5 fon-nula (26) wherein R 8 is as defined for a compound of formula (I) and X is halogen, can be made by reaction of a substituted toluene of formula (25) wherein R 8 is as defined for a compound of formula (I), with a halogenation agent, such as halogen of formula X 2 wherein X is chlorine or bromine, in the presence of light, or a N-halosuccinimide of 0 N-X formula 0 wherein X is chlorine, bromine or iodine, in the presence of a radical 10 initiator, such as benzoyl peroxide, in a suitable solvent, such as carbon tetrachloride, and optionally in the presence of a light source, such as a 500 watt tungsten halogen lamp, at reflux. 32) Benzyl cyanides of formula (27) wherein R 8 is as defined for a compound of fonnula (I) can be made by reaction of a compound of formula (26) as defined in 31) 15 with a metal cyanide, such as potassium cyanide, in a suitable solvent, such as ethanol, at reflux. 33) Phenyl acetic acids of formula (28) wherein R 8 is as defined for a compound of fonnula (I) can be made by reaction of a compound of formula (27) as defined in 32) by hydrolysis using aqueous acid or alkali, but preferably aqueous acid, such as aqueous 20 sulfuric acid, at reflux.
WO 2008/071918 PCT/GB2007/004662 Scheme 11
COOR
16 COOR 1 COOR 16 nitrating mixture reduction RS 8 R 8 R 8 e.g. HNO 3 , H 2
SO
4 e.g. Fe, HCI
NO
2 NH (29) (30) (31) 2 diazotisation e.g. HNO 2 , CuCN, KCN COOR RaR (32) 34) Nitro compounds of formula (30) wherein R 8 is as defined for compounds of 5 formula (1) and Ri 6 is as defined in 1), can be made by nitration of a compound of formula (29) wherein R 8 is as defined for compounds of formula (1) and R 16 is as defined in 1), with a nitration mixture, for example fuming nitric acid and concentrated sulfuric acid, as shown in Scheme 11. 35) Amino compounds of formula (31) wherein R8 is as defined for compounds 10 of formula (1) and R1 6 is as defined in 1), can be made by reduction of a compound of formula (30) as defined in 34), using standard reducing conditions, for example, iron filings in aqueous hydrochloric acid. 36) Compounds of formula (32) wherein R8 is as defined for compounds of formula (1), R 16 is as defined in 1), and R 1 9 is cyano, C-C 4 alkylthio, halo, or hydroxy, 15 can be made by reaction of a compound of formula (31) as defined in 35), by diazotisation, for example by reaction with an alkyl nitrite, in the presence of a suitable nucleophile, for example potassium cyanide, in the presence of a copper salt; for example cuprous cyanide, in a suitable solvent, such as acetonitrile.
WO 2008/071918 PCT/GB2007/004662 Scheme 12 Suzuki coupling e.g. R 1
B(OH)
2 or 16 R 2
B(OH)
2 , 16 COOR Pd catalyst, ligand N COOR R or R NH or Stille coupling, N H e.g. R1Sn(R 22
)
3 or 2 (33) R2Sn(R22 )3' (34) Pd catalyst, ligand 37) Compounds of formula (36) wherein R' and R 2 are as defined for compounds of formula (I) and Ri 6 is defined as in 1), can be made from a compound of formula (33) 5 where X is halogen, such as chlorine, bromine or iodine, as shown in Scheme 12. This can be achieved by Suzuki coupling using a boronic acid R 1
B(OH)
2 or R 2
B(OH)
2 in the presence of a palladium catalyst, such as palladium(II) acetate, in the presence of a ligand, such as 2'-dicyclohexylphosphino-2,6-dimethoxy- 1,1 '-biphenyl, in the presence of a base, such as potassium phosphate, in a suitable solvent, such as a mixture of toluene 10 and water, at a temperature of 50'C to 150'C, preferably of 100 0 C to 120'C, optionally using microwave heating. Alternatively, Stille coupling can be used, using a tin reagent R'Sn(R 2 2
)
3 or R 2 Sn(R 2
)
3 wherein R 22 is CI-C 6 alkyl in the presence of a palladium catalyst, such as palladium(II) chloride, in the presence of a ligand, such as tri-tertiary butylphosphine, in a suitable solvent, such as NN-dimethylformamide or acetonitrile, at 15 a temperature of 20'C to 150'C, preferably of 75'C to 120'C. Scheme 13
H
2 N NH I 1 (36) R 2 N
R
2 N COOH IR 0 1~ NH H 2 0
H
2 N H 0 base R N N 0 base R' N NH HH 2 (35) (37) (38)
R
1 6 0H acid catalyst R2 N COOR 1 N R N
NH
2 (39) WO 2008/071918 PCT/GB2007/004662 38) Although 3-amino-5-pyrazinecarboxylate esters of formula (39) wherein R 1 and R 2 are as defined for a compound of formula (I) and R 1 6 is as defined in 1), are known in the literature, for example in J. Med. Chem. (1967), 10, 66; J. Med. Chem. (1967), 10, 899; and J. Med. Chem. (1967), 10, 598, there is a need to make these 5 compounds using a shorter or more convenient syntheses. For example, a compound of formula (37) wherein R' and R 2 are as defined for a compound of formula (I), can be synthesised by condensation of diaminouracil of formula (35) or a salt thereof with a diketone or ketoaldehyde of formula (36) wherein R' and R 2 are as defined for a compound of formula (I), in the presence of a base, such as aqueous ammonia. 10 39) A pyrazine amino acid of formula (38) wherein R 1 and R 2 are as defined for a compound of formula (I), can be formed by opening the ring of a compound of formula (37) wherein R 1 and R 2 are as defined for a compound of formula (I), in the presence of a base, such as sodium hydroxide, and water, optionally using microwave heating. 40) A compound of formula (39) wherein R 1 and R 2 are as defined for a 15 compound of formula (I) and R 1 6 is as defined in 1), can be made from a compound of formula (38) wherein R' and R 2 are as defined for a compound of formula (I), for example by esterification with an alcohol of formula R 16 OH wherein R1 6 is as defined in 1), such as methanol, in the presence of an acid catalyst, such as acetyl chloride. 20 The compounds of formula (I) according to the invention can be used as herbicides in unmodified form, as obtained in the synthesis, but they are generally formulated into herbicidal compositions in various ways using fonnulation adjuvants, such as carriers, solvents and surface-active substances. The formulations can be in various physical forns, e.g. in the form of dusting powders, gels, wettable powders, 25 water-dispersible granules, water-dispersible tablets, effervescent pellets, enmulsifiable concentrates, microemulsifiable concentrates, oil-in-water emulsions, oil-flowables, aqueous dispersions, oily dispersions, suspo-emulsions, capsule suspensions, emulsifiable granules, soluble liquids, water-soluble concentrates (with water or a water miscible organic solvent as carrier), impregnated polymer films or in other forms known 30 e.g. from the Manual on Development and Use of FAO Specifications for Plant Protection Products, 5th Edition, 1999. Such formulations can either be used directly or they are diluted prior to use. The dilutions can be made, for example, with water, liquid fertilisers, micronutrients, biological organisms, oil or solvents.
WO 2008/071918 PCT/GB2007/004662 The formulations can be prepared e.g. by mixing the active ingredient with the formulation adjuvants in order to obtain compositions in the form of finely divided solids, granules, solutions, dispersions or emulsions. The active ingredients can also be formulated with other adjuvants, such as finely divided solids, mineral oils, oils of 5 vegetable or animal origin, modified oils of vegetable or animal origin, organic solvents, water, surface-active substances or combinations thereof. The active ingredients can also be contained in very fine microcapsules consisting of a polymer. Microcapsules contain the active ingredients in a porous carrier. This enables the active ingredients to be released into the environment in controlled amounts (e.g. slow-release). Microcapsules 10 usually have a diameter of from 0.1 to 500 microns. They contain active ingredients in an amount of about from 25 to 95 % by weight of the capsule weight. The active ingredients can be in the form of a monolithic solid, in the form of fine particles in solid or liquid dispersion or in the form of a suitable solution. The encapsulating membranes comprise, for example, natural or synthetic rubbers, cellulose, styrene/butadiene copolymers, 15 polyacrylonitrile, polyacrylate, polyesters, polyamides, polyureas, polyurethane or chemically modified polymers and starch xanthates or other polymers that are known to the person skilled in the art in this connection. Alternatively, very fine microcapsules can be forced in which the active ingredient is contained in the form of finely divided particles in a solid matrix of base substance, but the microcapsules are not themselves 20 encapsulated. The formulation adjuvants that are suitable for the preparation of the compositions according to the invention are known per se. As liquid carriers there may be used: water, toluene, xylene, petroleum ether, vegetable oils, acetone, methyl ethyl ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone, amyl acetate, 2 25 butanone, butylene carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl esters of acetic acid, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, NN-dimethylfornamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene 30 glycol dibenzoate, diproxitol, alkylpyrrolidone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1 -trichloroethane, 2-heptanone, alpha-pinene, d-limonene, ethyl lactate, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, gamma butyrolactone, glycerol, glycerol acetate, glycerol diacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, WO 2008/071918 PCT/GB2007/004662 isopropylbenzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxy propanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octa decanoic acid, octylamine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene 5 glycol (PEG400), propionic acid, propyl lactate, propylene carbonate, propylene glycol, propylene glycol methyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylenesulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, propylene glycol methyl ether, diethylene glycol methyl ether, methanol, ethanol, isopropanol, and alcohols of higher molecular weight, 10 such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, ethylene glycol, propylene glycol, glycerol, N-methyl-2-pyrrolidone and the like. Water is generally the carrier of choice for diluting the concentrates. Suitable solid carriers are, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed husks, wheat flour, 15 soybean flour, pumice, wood flour, ground walnut shells, lignin and similar substances, as described, for example, in CFR 180.1001. (c) & (d). A large number of surface-active substances can advantageously be used in both solid and liquid formulations, especially in those formulations which can be diluted with a carrier prior to use. Surface-active substances may be anionic, cationic, non-ionic or 20 polymeric and they can be used as emulsifiers, wetting agents or suspending agents or for other purposes. Typical surface-active substances include, for example, salts of alkyl sulfates, such as diethanolammonium lauryl sulfate; salts of alkylarylsulfonates, such as calcium dodecylbenzenesulfonate; alkylphenol/alkylene oxide addition products, such as nonylphenol ethoxylate; alcohol/alkylene oxide addition products, such as tridecylalcohol 25 ethoxylate; soaps, such as sodium stearate; salts of alkylnaphthalenesulfonates, such as sodium dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinate salts, such as sodium di(2-ethylhexyl)sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryltrimethylammonium chloride, polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and 30 propylene oxide; and salts of mono- and di-alkylphosphate esters; and also further substances described e.g. in "McCutcheon's Detergents and Emulsifiers Annual" MC Publishing Corp., Ridgewood New Jersey, 1981. Further adjuvants that can usually be used in pesticidal formulations include crystallisation inhibitors, viscosity modifiers, suspending agents, dyes, anti-oxidants, WO 2008/071918 PCT/GB2007/004662 foaming agents, light absorbers, mixing auxiliaries, antifoams, complexing agents, neutralising or pH-modifying substances and buffers, corrosion inhibitors, fragrances, wetting agents, take-up enhancers, micronutrients, plasticisers, glidants, lubricants, dispersants, thickeners, antifreezes, microbicides, and also liquid and solid fertilisers. 5 The compositions according to the invention can additionally include an additive comprising an oil of vegetable or animal origin, a mineral oil, alkyl esters of such oils or mixtures of such oils and oil derivatives. The amount of oil additive in the composition according to the invention is generally from 0.01 to 10 %, based on the spray mixture. For example, the oil additive can be added to the spray tank in the desired concentration 10 after the spray mixture has been prepared. Preferred oil additives comprise mineral oils or an oil of vegetable origin, for example rapeseed oil, olive oil or sunflower oil, emulsified vegetable oil, such as AMIGO® (Rh6ne-Poulenc Canada Inc.), alkyl esters of oils of vegetable origin, for example the methyl derivatives, or an oil of animal origin, such as fish oil or beef tallow. A preferred additive contains, for example, as active 15 components essentially 80 % by weight alkyl esters of fish oils and 15 % by weight methylated rapeseed oil, and also 5 % by weight of customary emulsifiers and pH modifiers. Especially preferred oil additives comprise alkyl esters of C 8
-C
22 fatty acids, especially the methyl derivatives of C 12
-C
18 fatty acids, for example the methyl esters of lauric acid, palmitic acid and oleic acid, being of importance. Those esters are known as 20 methyl laurate (CAS-1 11-82-0), methyl palmitate (CAS-1 12-39-0) and methyl oleate (CAS-l 12-62-9). A preferred fatty acid methyl ester derivative is Emery® 2230 and 2231 (Cognis GmbH). Those and other oil derivatives are also known from the Compendium of Herbicide Adjuvants, 5th Edition, Southern Illinois University, 2000. The application and action of the oil additives can be further improved by 25 combination with surface-active substances, such as non-ionic, anionic or cationic surfactants. Examples of suitable anionic, non-ionic and cationic surfactants are listed on pages 7 and 8 of WO 97/34485. Preferred surface-active substances are anionic surfactants of the dodecylbenzylsulfonate type, especially the calcium salts thereof, and also non-ionic surfactants of the fatty alcohol ethoxylate type. Special preference is given 30 to ethoxylated C 12
-C
22 fatty alcohols having a degree of ethoxylation of from 5 to 40. Examples of commercially available surfactants are the Genapol types (Clariant AG). Also preferred are silicone surfactants, especially polyalkyl-oxide-modified heptamethyltriloxanes which are commercially available e.g. as Silwet L-77@, and also perfluorinated surfactants. The concentration of the surface-active substances in relation WO 2008/071918 PCT/GB2007/004662 to the total additive is generally from 1 to 30 % by weight. Examples of oil additives consisting of mixtures of oil or mineral oils or derivatives thereof with surfactants are Edenor ME SU@, Turbocharge@ (Syngenta AG, CH) or ActipronC (BP Oil UK Limited, GB). 5 If desired, it is also possible for the mentioned surface-active substances to be used in the formulations on their own, that is to say without oil additives. Furthermore, the addition of an organic solvent to the oil additive/surfactant mixture may contribute to an additional enhancement of action. Suitable solvents are, for example, Solvesso@ (ESSO) or Aromatic Solvent@ (Exxon Corporation). The 10 concentration of such solvents can be from 10 to 80 % by weight of the total weight. Oil additives that are present in admixture with solvents are described, for example, in US-A 4,834,908. A commercially available oil additive disclosed therein is known by the name MERGE@ (BASF Corporation). A further oil additive that is preferred according to the invention is SCORE@ (Syngenta Crop Protection Canada). 15 In addition to the oil additives listed above, for the purpose of enhancing the action of the compositions according to the invention it is also possible for fonnulations of alkylpyrrolidones (e.g. Agrimax®) to be added to the spray mixture. Fonnulations of synthetic lattices, e.g. polyacrylamide, polyvinyl compounds or poly-1 -p-menthene (e.g. Bond@, Courier@ or Emerald@) may also be used. It is also possible for solutions that 20 contain propionic acid, for example Eurogkem Pen-e-trate@, to be added to the spray mixture as action-enhancing agent. The herbicidal compositions generally comprise from 0.1 to 99 % by weight, especially from 0.1 to 95 % by weight, compounds of formula (I) and from 1 to 99.9 % by weight of a formulation adjuvant which preferably includes from 0 to 25 % by weight 25 of a surface-active substance. Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ dilute formulations. The rates of application of compounds of fonnula (I) may vary within wide limits and depend on the nature of the soil, the method of application (pre- or post-emergence; seed dressing; application to the seed furrow; no tillage application etc.), the crop plant, 30 the grass or weed to be controlled, the prevailing climatic conditions, and other factors governed by the method of application, the time of application and the target crop. The compounds of formula (I) according to the invention are generally applied at a rate of from 10 to 2000 g/ha, especially from 50 to 1000 g/ha.
WO 2008/071918 PCT/GB2007/004662 Preferred formulations have especially the following compositions (% = percent by weight): Emulsifiable concentrates: active ingredient: 1 to 95 preferably 60 to 90 % 5 surface-active agent: 1 to 30 preferably 5 to 20 % liquid carrier: 1 to 80 preferably 1 to 35 % Dusts: active ingredient: 0.1 to 10 %, preferably 0.1 to 5 % solid carrier: 99.9 to 90 %, preferably 99.9 to 99 % 10 Suspension concentrates: active ingredient: 5 to 75 %, preferably 10 to 50 % water: 94 to 24 %, preferably 88 to 30 % surface-active agent: 1 to 40 %, preferably 2 to 30 % Wettable powders: 15 active ingredient: 0.5 to 90 preferably 1 to 80 % surface-active agent: 0.5 to 20 preferably 1 to 15 % solid carrier: 5 to 95 %, preferably 15 to 90 % Granules: active ingredient: 0.1 to 30 %, preferably 0.1 to 15 % 20 solid carrier: 99.5 to 70 %, preferably 97 to 85 % The following Examples further illustrate, but do not limit, the invention. Formulation Examples for herbicides of formula (1) (% =% by weight) 25 Fl. Emulsifiable concentrates a) b) c) d) active ingredient 5 % 10 % % 50% calcium dodecylbenzenesulfonate 6 % 8 % % 8% castor oil polyglycol ether 4 % - 4% 4% (36 mol of ethylene oxide) 30 octylphenol polyglycol ether - 4% - 2% (7-8 mol of ethylene oxide) NMP - - 10% 20% arom. hydrocarbon mixture 85 % 78 % 55 % 16 %
C
9
-CI
2 WO 2008/071918 PCT/GB2007/004662 Emulsions of any desired concentration can be obtained from such concentrates by dilution with water. F2. Solutions a) b) c) d) 5 active ingredient 5 % 10 % 50 % 90 % 1 -methoxy-3-(3-methoxy propoxy)-propane - 20 % 20 % polyethylene glycol MW 400 20 % 10 % - NMP - - 30% 10% 10 arom. hydrocarbon mixture 75 % 60 % - C 9
-C
2 The solutions are suitable for use in the form of microdrops. F3. Wettable powders a) b) c) d) 15 active ingredient 5 % 25 % 50 % 80 % sodium lignosulfonate 4 % - 3 % sodium lauryl sulfate 2 % 3 % - 4 % sodium diisobutylnaphthalene sulfonate - 6% 5% 6% 20 octylphenol polyglycol ether - 1 % 2 % (7-8 mol of ethylene oxide) highly dispersed silicic acid 1 % 3 % 5 % 10 % kaolin 88% 62% 35% The active ingredient is mixed thoroughly with the adjuvants and the mixture is 25 thoroughly ground in a suitable mill, affording wettable powders which can be diluted with water to give suspensions of any desired concentration. F4. Coated granules a) b) c) active ingredient 0.1 % 5 % 15 % 30 highly dispersed silicic acid 0.9 % 2 % 2 % inorganic carrier 99.0 % 93 % 83 % (diameter 0.1 - 1 mm) e.g. CaCO 3 or SiO 2 WO 2008/071918 PCT/GB2007/004662 The active ingredient is dissolved in methylene chloride and applied to the carrier by spraying, and the solvent is then evaporated off in vacuo. F5. Coated granules a) b) c) 5 active ingredient 0.1 % 5 % 15 % polyethylene glycol MW 200 1.0 % 2 % 3 % highly dispersed silicic acid 0.9 % 1 % 2 % inorganic carrier 98.0 % 92 % 80 % (diameter 0.1 - 1 mn) 10 e.g. CaCO 3 or SiO 2 The finely ground active ingredient is uniformly applied, in a mixer, to the carrier moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner. 15 F6. Extruder granules a) b) c) d) active ingredient 0.1 % 3 O/ 5% 15% sodium lignosulfonate 1.5 % 2 % 3 % 4 % carboxymethylcellulose 1.4 % 2 % 2 % 2 % kaolin 97.0% 93% 90% 79% 20 The active ingredient is mixed and ground with the adjuvants, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air. F7. Dusts a) b) c) active ingredient 0.1 % 1 % 5 % 25 talcum 39.9 % 49 % 35 % kaolin 60.0 % 50 % 60 % Ready-to-use dusts are obtained by mixing the active ingredient with the carriers and grinding the mixture in a suitable mill.
WO 2008/071918 PCT/GB2007/004662 F8. Suspension concentrates a) b) c) d) active ingredient 3 % 10 % 25 % 50 % ethylene glycol 5% 5% 5% 5% nonylphenol polyglycol ether - 1 % 2 % 5 (15 mol of ethylene oxide) sodium lignosulfonate 3 % 3 % 4 % 5 % carboxymethylcellulose 1 % 1 % 1 % 1 % 37 % aqueous formaldehyde 0.2 % 0.2 % 0.2 % 0.2 % solution 10 silicone oil emulsion 0.8% 0.8% 0.8% 0.8% water 87% 79% 62% 38% The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired concentration can be obtained by dilution with water. 15 The invention also relates to a method of controlling plants which comprises applying to the plants or to the locus thereof a herbicidally effective amount of a compound of formula I. The invention also relates to a method of inhibiting plant growth which comprises 20 applying to the plants or to the locus thereof a herbicidally effective amount of a compound of formula I. The invention also relates to a method of selectively controlling grasses and weeds in crops of useful plants which comprises applying to the useful plants or locus thereof or to the area of cultivation a herbicidally effective amount of a compound of 25 formula 1. Crops of useful plants in which the composition according to the invention can be used include perennial crops, such as citrus fruit, grapevines, nuts, oil palms, olives, pome fruit, stone fruit and rubber, and annual arable crops, such as cereals, for example barley and wheat, cotton, oilseed rape, maize, rice, soy beans, sugar beet, sugar cane, 30 sunflowers, ornamentals and vegetables, especially cereals and maize. The grasses and weeds to be controlled may be both monocotyledonous species, for example Agrostis, Alopecurus, Avena, Bromus, Cyperus, Digitaria, Echinochloa, Lolium, Monochoria, Rottboellia, Sagittaria, Scirpus, Setaria, Sida and Sorghum, and dicotyledonous species, for example Abutilon, Anaranthus, Chenopodium, WO 2008/071918 PCT/GB2007/004662 Chrysanthemum, Galium, Ipomoea, Nasturtium, Sinapis, Solanum, Stellaria, Veronica, Viola and Xanthium. Crops are to be understood as also including those crops which have been rendered tolerant to herbicides or classes of herbicides (e.g. ALS-, GS-, EPSPS-, PPO 5 and HPPD-inhibitors) by conventional methods of breeding or by genetic engineering. An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding is Clearfield@ summer rape (canola). Examples of crops that have been rendered tolerant to herbicides by genetic engineering methods include e.g. glyphosate- and glufosinate-resistant maize varieties commercially available 10 under the trade names RoundupReady@ and LibertyLink@. Crops are also to be understood as being those which have been rendered resistant to harmful insects by genetic engineering methods, for example Bt maize (resistant to European corn borer), Bt cotton (resistant to cotton boll weevil) and also Bt potatoes (resistant to Colorado beetle). Examples of Bt maize are the Bt 176 maize hybrids of 15 NK@ (Syngenta Seeds). The Bt toxin is a protein that is formed naturally by Bacillus thuringiensis soil bacteria. Examples of toxins, or transgenic plants able to synthesise such toxins, are described in EP-A-451 878, EP-A-374 753, WO 93/07278, WO 95/34656, WO 03/052073 and EP-A-427 529. Examples of transgenic plants comprising one or more genes that code for an insecticidal resistance and express one or more toxins 20 are KnockOut@ (maize), Yield Gard@ (maize), NuCOTIN33B@ (cotton), Bollgard@ (cotton), NewLeaf@ (potatoes), NatureGard@ and Protexcta@. Plant crops or seed material thereof can be both resistant to herbicides and, at the same time, resistant to insect feeding ("stacked" transgenic events). For example, seed can have the ability to express an insecticidal Cry3 protein while at the same time being tolerant to glyphosate. 25 Crops are also to be understood as being those which are obtained by conventional methods of breeding or genetic engineering and contain so-called output traits (e.g. improved storage stability, higher nutritional value and improved flavour). Areas under cultivation include land on which the crop plants are already growing and land intended for cultivation with those crop plants. 30 The compounds of formula I according to the invention can also be used in combination with one or more further herbicides. In particular, the following mixtures of the compound of formula I are important: WO 2008/071918 PCT/GB2007/004662 Mixtures of a compound of formula I with a synthetic auxin (e.g. compound of formula I + clopyralid (162), compound of fonnula I + 2,4-D (211), compound of formula I + dicamba (228), compound of formula I + MCPA (499), compound of formula I + quinclorac (712), or compound of formula I + aminopyralid (CAS RN 5 150114-71-9)). Mixtures of a compound of formula I with diflufenzopyr (252). Mixtures of a compound of fonnula I with an acetanilide (e.g. compound of formula I + acetochlor (5), compound of formula I + dimethenamid (260), compound of formula I + metolachlor (548), compound of formula I + S-metolachlor (549), or 10 compound of formula I + pretilachlor (656)). Mixtures of a compound of formula I with flamprop-M (355). Mixtures of a compound of formula I with flufenacet (BAY FOE 5043) (369). Mixtures of a compound of formula I with pyroxasulfone (CAS RN 447399-55 5). 15 Mixiures of a compound of formula I with a triazine (e.g. compound of formula I + atrazine (37), or compound of formula I + terbuthylazine (775)). Mixtures of a compound of formula I with an HPPD inhibitor (e.g. compound of formula I + isoxaflutole (479), compound of formula I + mesotrione (515), compound of formula I + pyrasulfotole (CAS RN 365400-11-9), compound of fonnula I + sulcotrione 20 (747), compound of formula I + tembotrione (CAS RN 335104-84-2), compound of formula I + topramezone (CAS RN 210631-68-8), compound of formula I + 4-hydroxy 3-[[2-[(2-methoxyethoxy)methyl]-6-(trifluoromethyl)-3-pyridinyl]carbonyl] bicyclo[3.2.1]oct-3-en-2-one (CAS RN 352010-68-5), or compound of formula I + 4 hydroxy-3-[[2-(3-methoxypropyl)-6-(difluoromethyl)-3-pyridinyl]carbonyl] 25 bicyclo[3.2.1]oct-3-en-2-one). Mixtures of a compound of formula I with an HPPD inhibitor and a triazine. Mixtures of a compound of formula I with glyphosate (419). Mixtures of a compound of fonnula I with glyphosate and an HPPD inhibitor (e.g. compound of formula I + glyphosate + isoxaflutole, compound of formula I + 30 glyphosate + mesotrione, compound of formula I + glyphosate + pyrasulfotole (CAS RN 365400-11-9), compound of fonnula I + glyphosate + sulcotrione, compound of formula I + glyphosate + tembotrione, compound of fonnula I + glyphosate + topramezone, compound of formula I + glyphosate + 4-hydroxy-3-[[2-[(2-methoxyethoxy)methyl]-6 (trifluoromethyl)-3-pyridinyl]carbonyl]-bicyclo[3.2.1]oct-3-en-2-one, or compound of WO 2008/071918 PCT/GB2007/004662 fonnula I + glyphosate + 4-hydroxy-3-[[2-(3-methoxypropyl)-6-(difluoromethyl)-3 pyridinyl]carbonyl]-bicyclo[3.2.1]oct-3-en-2-one). Mixtures of a compound of formula I with glufosinate-ammonium (418). Mixtures of a compound of formula I with glufosinate-ammonium and an HPPD 5 inhibitor (e.g. compound of formula I + glufosinate-ammonium + isoxaflutole, compound of formula I + glufosinate-ammonium + mesotrione, compound of formula I + glufosinate-ammonium + pyrasulfotole (CAS RN 365400-11-9), compound of formula I + glufosinate-ammonium + sulcotrione, compound of formula I + glufosinate-ammonium + tembotrione, compound of formula I + glufosinate-ammonium + topramezone, 10 compound of formula I + glufosinate-ammonium + 4-hydroxy-3-[[2-[(2 methoxyethoxy)methyl]-6-(trifluoromethyl)-3-pyridinyl]carbonyl]-bicyclo[3.2.1]oct-3 en-2-one, or compound of formula I + glufosinate-ammonium + 4-hydroxy-3-[[2-(3 methoxypropyl)-6-(difluoromethyl)-3-pyridinyl]carbonyl]-bicyclo[3.2.1]oct-3-en-2-one). Mixtures of a compound of formula I with an ALS or an AHAS inhibitor (e.g. 15 compound of formula I + bensulfuron-methyl (64), compound of formula I + chlorimuron-ethyl (135), compound of formula I + cloransulam-methyl (164), compound of fonnula I + florasulam (359), compound of formula I + flucarbazone-sodium (364), compound of formula I + imazamox (451), compound of formula I + imazapyr (453), compound of fonnula I + imazethapyr (455), compound of formula I + iodosulfuron 20 methyl-sodium (466), compound of formula I + mesosulfuron-methyl (514), compound of formula I + nicosulfuron (577), compound of formula I + penoxsulam (622), compound of formula I + pyroxsulam (triflosulam) (CAS RN 422556-08-9), compound of formula I + thifensulfuron-methyl (thiameturon-methyl) (795), compound of fonnula I + triasulfuron (817), compound of fonnula I + tribenuron-methyl (822), compound of 25 formula I + trifloxysulfuron-sodium (833), compound of fonnula I + thiencarbazone (4 [(4,5-dihydro-3-methoxy-4-methyl-5-oxo-1H-1,2,4-triazol-1-yl)carbonylsulfamoyl]-5 methylthiophene-3-carboxylic acid, BAY636)), or compound of fonnula I + thiencarbazone-methyl (methyl 4-[(4,5-dihydro-3-methoxy-4-methyl-5-oxo-1H-1,2,4 triazol-1-yl)carbonylsulfamoyl]-5-methylthiophene-3-carboxylate, CAS RN 317815-83 30 1, BAY636-methyl)). Mixtures of a compound of fonnula I with a PPO inhibitor (e.g. compound of fonnula I + butafenacil (101), compound of formula I + carfentrazone-ethyl (121), compound of fonnula I + cinidon-ethyl (152), compound of formula I + flumioxazin (376), compound of formula I + fomesafen (401), or compound of fonnula I + [3-[2- WO 2008/071918 PCT/GB2007/004662 chloro-4-fluoro-5-(1 -nethyl-6-trifluoromethyl-2,4-dioxo- 1,2,3,4-tetrahydropyrimidin-3 yl)phenoxy] -2-pyridyloxy] acetic acid ethyl ester) (CAS RN 353292-31-6). Mixtures of a compound of formula I with an ACCase inhibitor (e.g. compound of formula I + butroxydim (106), compound of formula I + clethodim (155), compound 5 of formula I + clodinafop-propargyl (156), compound of formula I + cycloxydim (190), compound of formula I + cyhalofop-butyl (195), compound of fonnula I + diclofop methyl (238), compound of formula I + fenoxaprop-P-ethyl (339), compound of formula I + fluazifop-butyl (361), compound of formula I + fluazifop-P-butyl (362), compound of formula I + haloxyfop (427), compound of formula I + haloxyfop-P (428), compound of 10 formula I + propaquizafop (670), compound of formula I + quizalofop (717), compound of formula I + quizalofop-P (718), compound of formula I + sethoxydim (726), compound of formula I + tepraloxydim (771), compound of formula I + tralkoxydim (811)), or compound of formula I + pinoxaden (CAS RN 243973-20-8). Mixtures of a compound of formula I with prosulfocarb (683), or a compound of 15 fonnula I with tri-allate (816). Mixtures of a compound of formula I with bromoxynil (95), a compound of formula I with chloridazon (134), a compound of formula I with chlorotoluron (143), a compound of formula I with diuron (281), or a compound of formula I with metribuzin (554). 20 Mixtures of a compound of formula I with clomazone (159), a compound of formula I with diflufenican (251), a compound of formula I with flurochloridone (389), or a compound of formula I with flurtamone (392). Mixtures of a compound of fonnula I with pendimethalin (621) or a compound of formula I with trifluralin (836). 25 Mixtures of a compound of formula I with difenzoquat metilsulfate (248). Mixtures of a compound of formula I with diquat dibromide (276). Mixtures of a compound of formula I with paraquat dichloride (614). The mixing partners of the compound of formula I may also be in the form of esters or salts, as mentioned e.g. in The Pesticide Manual, 13t Edition (BCPC), 2003. 30 The reference to glufosinate-ammonium also applies to glufosinate, the reference to cloransulam-methyl also applies to cloransulam, the reference to dimethenamid also applies to dimethenamid-P, the reference to flamprop-M also applies to flamprop, and the reference to pyrithiobac-sodium also applies to pyrithiobac, etc.
WO 2008/071918 PCT/GB2007/004662 The mixing ratio of the compound of formula I to the mixing partner is preferably from 1: 100 to 1000:1. The mixtures can advantageously be used in the above-mentioned formulations (in which case "active ingredient" relates to the respective mixture of compound of 5 formula I with the mixing partner). Additionally, one or more of the following herbicides can be used in combination with a compound of formula I according to the invention or in combination with a mixture as described above: acifluorfen-sodium (7), aclonifen (8), acrolein (10), alachlor (14), alloxydim (18), ametryn (20), amicarbazone (21), amidosulfuron (22), amitrole 10 (aminotriazole) (25), ammonium sulfamate (26), anilofos (31), asulam (36), aviglycine (39), azafenidin (CAS RN 68049-83-2), azimsulfuron (43), BAS 800H (CAS RN 372137-35-4), beflubutamid (55), benazolin (57), bencarbazone (CAS RN 173980-17-1), benfluralin (59), benfuresate (61), bensulide (65), bentazone (67), benzfendizone (CAS RN 158755-95-4), benzobicyclon (69), benzofenap (70), bilanafos (bialaphos) (77), 15 bispyribac-sodiun (82), borax (86), bromacil (90), bromobutide (93), bromofenoxim (CAS RN 13181-17-4), butachlor (100), butamifos (102), butralin (105), butylate (108), cafenstrole (110), carbetamide (117), chlorbromuron (CAS RN 13360-45-7), chlorflurenol-methyl (133), chloroacetic acid (138), chlorprophan (144), chlorsulfuron (147), chlorthal-dimethyl (148), cinmethylin (153), cinosulfuron (154), clomeprop (160), 20 cumyluron (180), cyanamide (182), cyanazine (183), cyclanilide (186), cycloate (187), cyclosulfamuron (189), daimuron (213), dalapon (214), dazomet (216), desmedipham (225), desmetryn (CAS RN 1014-69-3), dichlobenil (229), dichlorprop (234), dichlorprop-P (235), diclosulam (241), dimefuron (256), dimepiperate (257), dimethachlor (258), dimethametryn (259), dimethipin (261), dimethylarsinic acid (264), 25 dinitramine (268), dinoterb (272), diphenamid (274), dipropetryn (CAS RN 4147-51-7), dithiopyr (280), DNOC (282), DSMA (CAS RN 144-21-8), endothal (295), EPTC (299), esprocarb (303), ethalfluralin (305), ethametsulfuron-methyl (306), ethephon (307), ethofumesate (311), ethoxyfen (CAS RN 188634-90-4), ethoxyfen-ethyl (CAS RN 131086-42-5), ethoxysulfuron (314), etobenzanid (318), fentrazamide (348), ferrous 30 sulfate (353), flazasulfuron (356), fluazolate (isopropazol) (CAS RN 174514-07-9), flucetosulfuron (CAS RN 412928-75-7), fluchloralin (365), flufenpyr-ethyl (371), flumetralin (373), flumetsulam (374), flumiclorac-pentyl (375), flumipropyn (flumipropin) (CAS RN 84478-52-4), fluometuron (378), fluoroglycofen-ethyl (380), flupoxam (CAS RN 119126-15-7), flupropacil (CAS RN 120890-70-2), flupropanate WO 2008/071918 PCT/GB2007/004662 (383), flupyrsulfuron-methyl-sodium (384), flurenol (387), fluridone (388), fluroxypyr (390), fluthiacet-methyl (395), foramsulfuron (402), fosamine (406), halosulfuron-methyl (426), HC-252 (429), hexazinone (440), imazamethabenz-methyl (450), imazapic (452), imazaquin (454), imazosulfuron (456), indanofan (462), ioxynil (467), isoproturon (475), 5 isouron (476), isoxaben (477), isoxachlortole (CAS RN 141112-06-3), isoxapyrifop (CAS RN 87757-18-4), karbutilate (482), lactofen (486), lenacil (487), linuron (489), MCPA-thioethyl (500), MCPB (501), mecoprop (503), mecoprop-P (504), mefenacet (505), mefluidide (507), metam (519), metanifop (mefluoxafop) (520), metamitron (521), metazachlor (524), methabenzthiazuron (526), methazole (CAS RN 20354-26-1), 10 methylarsonic acid (536), methyldymron (539), methyl isothiocyanate (543), metobenzuron (547), metobromuron (CAS RN 3060-89-7), metosulam (552), metoxuron (553), metsulfuron-methyl (555), MK-616 (559), molinate (560), monolinuron (562), MSMA (CAS RN 2163-80-6), naproanilide (571), napropamide (572), naptalan (573), neburon (574), nipyraclofen (CAS RN 99662-11-0), n-methyl-glyphosate, nonanoic acid 15 (583), norflurazon (584), oleic acid (fatty acids) (593), orbencarb (595), orthosulfamuron (CAS RN 213464-77-8), oryzalin (597), oxadiargyl (599), oxadiazon (600), oxasulfuron (603), oxazielomefone (604), oxyfluorfen (610), pebulate (617), pentachlorophenol (623), pentanochlor (624), pentoxazone (625), pethoxamid (627), petrolium oils (628), phenmedipham (629), picloram (645), picolinafen (646), piperophos (650), 20 primisulfuron-methyl (657), prodiamine (661), profluazol (CAS RN 190314-43-3), profoxydim (663), prohexadione calcium (664), prometon (665), prometryn (666), propachlor (667), propanil (669), propazine (672), propham (674), propisochlor (667), propoxycarbazone-sodium (procarbazone-sodium) (679), propyzamide (681), prosulfuron (684), pyraclonil (pyrazogyl) (CAS RN 158353-15-2), pyraflufen-ethyl 25 (691), pyrazolynate (692), pyrazosulfuron-ethyl (694), pyrazoxyfen (695), pyribenzoxim (697), pyributicarb (698), pyridafol (CAS RN 40020-01-7), pyridate (702), pyriftalid (704), pyriminobac-methyl (707), pyrimisulfan (CAS RN 221205-90-9), pyrithiobac sodium (709), quinmerac (713), quinoclamine (714), rimsulfuron (721), sequestrene, siduron (727), simazine (730), simetryn (732), sodium chlorate (734), sulfentrazone 30 (749), sulfometuron-methyl (751), sulfosate (CAS RN 81591-81-3), sulfosulfuron (752), sulfuric acid (755), tar oils (758), TCA-sodium (760), tebutam (CAS RN 35256-85-0), tebuthiuron (765), tefuryltrione (CAS RN 473278-76-1), terbacil (772), terbumeton (774), terbutryn (776), thenylchlor (789), thidiazimin (CAS RN 123249-43-4), thiazafluron (CAS RN 25366-23-8), thiazopyr (793), thiobencarb (797), tiocarbazil WO 2008/071918 PCT/GB2007/004662 (807), triaziflam (819), triclopyr (827), trietazine (831), triflusulfuron-methyl (837), trihydroxytriazine (CAS RN 108-80-5), trinexapac-ethyl (CAS RN 95266-40-3) and tritosulfuron (843). The mixing partners of the compound of formula I may also be in the form of 5 esters or salts, as mentioned e.g. in The Pesticide Manual, 13t Edition (BCPC), 2003. The reference to acifluorfen-sodium also applies to acifluorfen, and the reference to bensulfuron-methyl also applies to bensulfuron, etc. The mixing ratio of the compound of formula I to the mixing partner is preferably from 1: 100 to 1000:1. 10 The mixtures can advantageously be used in the above-mentioned formulations (in which case "active ingredient" relates to the respective mixture of compound of formula I with the mixing partner). The compounds of formula I according to the invention can also be used in combination with one or more safeners. Likewise, mixtures of a compound of formula I 15 according to the invention with one or more further herbicides can also be used in combination with one or more safeners. The safeners can be benoxacor (63), cloquintocet-mexyl (163), cyometrinil (CAS RN 78370-21-5), cyprosulfamide (CAS RN 221667-31-8), dichlormid (231), dicyclonon (CAS RN 79260-71-2), fenchlorazole-ethyl (331), fenclorim (332), flurazole (386), fluxofenim (399), furilazole (413) and the 20 corresponding R isomer, isoxadifen-ethyl (478), mefenpyr-diethyl (506), naphthalic anhydride (CAS RN 81-84-5), and oxabetrinil (598). Particularly preferred are mixtures of a compound of formula I with benoxacor and a compound of formula I with cloquintocet-mexyl. The safeners of the compound of formula I may also be in the form of esters or 25 salts, as mentioned e.g. in The Pesticide Manual, 13t Edition (BCPC), 2003. The reference to cloquintocet-mexyl also applies to cloquintocet, and the reference to fenchlorazole-ethyl also applies to fenchlorazole, etc. Preferably the mixing ratio of compound of formula I to safener is from 100:1 to 1:10, especially from 20:1 to 1:1. 30 The mixtures can advantageously be used in the above-mentioned formulations (in which case "active ingredient" relates to the respective mixture of compound of fonnula I with the safener). It is possible that the safener and a compound of formula I and one or more additional herbicide(s), if any, are applied simultaneously. For example, the safener, a compound of formula I and one or more additional herbicide(s), if any, WO 2008/071918 PCT/GB2007/004662 might be applied to the locus pre-emergence or might be applied to the crop post emergence. It is also possible that the safener and a compound of formula I and one or more additional herbicide(s), if any, are applied sequentially. For example, the safener might be applied before sowing the seeds as a seed treatment and a compound of formula 5 I and one or more additional herbicides, if any, might be applied to the locus pre emergence or might be applied to the crop post-emergence. Preferred mixtures of a compound of formula I with further herbicides and safeners include: Mixtures of a compound of formula I with a triazine and a safener. 10 Mixtures of a compound of formula I with glyphosate and a safener. Mixtures of a compound of formula I with glufosinate and a safener. Mixtures of a compound of formula I with isoxaflutole and a safener. Mixtures of a compound of formula I with isoxaflutole and a triazine and a safener. 15 Mixtures of a compound of formula I with isoxaflutole and glyphosate and a safener. Mixtures of a compound of formula I with isoxaflutole and glufosinate and a safener. Mixtures of a compound of formula I with mesotrione and a safener. 20 Mixtures of a compound of formula I with mesotrione and a triazine and a safener. Mixtures of a compound of formula I with mesotrione and glyphosate and a safener. Mixtures of a compound of formula I with mesotrione and glufosinate and a 25 safener. Mixtures of a compound of formula I with sulcotrione and a safener. Mixtures of a compound of formula I with sulcotrione and a triazine and a safener. Mixtures of a compound of fonnula I with sulcotrione and glyphosate and a 30 safener. Mixtures of a compound of formula I with sulcotrione and glufosinate and a safener. The following Examples further illustrate, but do not limit, the invention.
WO 2008/071918 PCT/GB2007/004662 Preparation Examples 1. Reactions which are covered by Scheme 1 Example 1.1: Preparation of 3-[2-(2-chloro-3,6-difluoro-phenyl)-acetylaminol-pyrazine 5 2-carboxylic acid methyl ester F (i) (COCl)2 N CO 2 Me 2C F N CO 2 Me N NH CI 0 F N NH 2 CI Oxalyl chloride (1.30 ml) was added dropwise to a solution of (2-chloro-3,6 difluoro-phenyl)-acetic acid (3.151 g) in dichloromethane (20 ml) and a drop of NN dimethylformamide was added to initiate the reaction. The reaction mixture was stirred at 10 ambient temperature for 1 hour. The solvent was evaporated to produce a colourless oil which was dissolved in acetonitrile (30 ml). This solution was then divided into three portions and each portion was added to a slurry of 3-amino-pyrazine-2-carboxylic acid methyl ester (0.76 g) in acetonitrile (15 ml). The reaction mixtures were heated in the microwave at 130'C for 40 minutes to produce dark red solutions that was stored at 15 ambient temperature for 16 hours. The samples were combined and concentrated to produce 3-[2-(2-chloro-3,6-difluoro-phenyl)-acetylanino]-pyrazine-2-carboxylic acid methyl ester as a dark orange solid (4.15 g). 1 H-NMR (400 MHz, CDCl 3 ): 4.02 (s, 3H), 4.22 (s, 2H), 7.02-7.10 (m, 1H), 7.11-7.17 (m, 1H), 8.41 (d, 1H), 8.61 (d, 1H), 10.8 (s, 1H) ppm. 20 Example 1.2: Preparation of 7-(2-chloro-3,6-difluoro-phenvl)-8-hYdroxy-5H-pyrido[2,3 blpyrazin-6-one
CO
2 Me F F K 2
CO
3 OH' Nq NH C1 F O0F NC CI H 3-[2-(2-Chloro-3,6-difluoro-phenyl)-acetylamino]-pyrazine-2-carboxylic acid 25 methyl ester (4.15 g) (Example 1.1) was heated with potassium carbonate (1.67 g) in N,N-dimethylformamide (50 ml) at 110 C for 2 hours and then stored at ambient WO 2008/071918 PCT/GB2007/004662 temperature for 16 hours. Water was added and the reaction mixture was acidified with aqueous hydrochloric acid (concentrated). A precipitate formed which was isolated by filtration. The residue was washed successively with water and hexane to produce 7-(2 chloro-3,6-difluoro-phenyl)-8-hydroxy-5H-pyrido[2,3-b]pyrazin-6-one as a brown solid 5 (2.88 g). 'H-NMR (400 MHz, d 6 -DMSO): 7.34-7.42 (m, 1H), 7.51-7.59 (m, 1H), 8.59 (d, 1H), 8.72 (d, 1H), 12.0 (bs, 1H), 12.4 (s, 1H) ppm. Example 1.3: Preparation of 2,2-dimethyl-propionic acid 7-(2-chloro-3,6-difluoro phenyl)-6-oxo-5,6-dihydro-pyrido[2,3-bipyrazin-8-vl ester F o OH N, cl O O F F CN pyridine N F H CI N N 0 10 H A mixture of 7-(2-chloro-3,6-difluoro-phenyl)-8-hydroxy-5H-pyrido[2,3 b]pyrazin-6-one (0.20 g) (Example 1.2), trimethylacetyl chloride (0.08 ml), and pyridine (0.05 ml) in dichloromethane (5 ml) was stirred at ambient temperature for two hours. The reaction mixture was diluted with ethyl acetate and water. The phases were 15 separated. The organic phase was dried over magnesium sulfate and concentrated to produce a yellow semi-crystalline oil. This was triturated in iso-hexane to produce 2,2 dimethyl-propionic acid 7-(2-chloro-3,6-difluoro-phenyl)-6-oxo-5,6-dihydro-pyrido[2,3 b]pyrazin-8-yl ester as a pale brown powder (0.113 g). 'H-NMR (400 MHz, CDCl 3 ): 1.21 (s, 9H), 7.08-7.13 (m, 1H), 7.21-7.27 (m, 1H), 8.55-8.57 (in, 2H), 9.51 (s, 1H) ppm. 20 WO 2008/071918 PCT/GB2007/004662 2. Reactions which are covered by Scheme 2 Example 2.1: Preparation of 2,2-dimethyl-propionic acid 7-(2-chloro-3,6-difluoro phenvl)-5-(2,2-difluoro-ethyl)-6-oxo-5,6-dihydro-pyrido[2,3-blpyrazin-8-yl ester (Compound No. A2 of Table A) Br F FF 0 0 0 F K2CO3, KI (N F NF CI CI N N 0 F H 5 F 1-Bromo-2,2-difluoroethane (0.113 g) was added to a mixture of 2,2-dimethyl propionic acid 7-(2-chloro-3,6-difluoro-phenyl)-6-oxo-5,6-dihydro-pyrido[2,3-b]pyrazin 8-yl ester (Example 1.3) (0.126 g), potassium carbonate (0.044 g) and potassium iodide (0.053 g) in acetonitrile (5 ml). The reaction mixture was heated in a microwave for 25 10 minutes at 120'C. The reaction mixture was concentrated and the residue was purified by column chromatography on silica gel (eluent: hexane / ethyl acetate, 8:2 to 1:1) to give Compound No. A2 of Table A as a yellow solid (0.083 g). Example 2.2: Preparation of 2,2-dimethyl-propionic acid 7-(2-chloro-3,6-difluoro 15 phenvl)-5-(2-fluoro-ethyl)-6-oxo-5,6-dihydro-pyrido[2,3-blpyrazin-8-vl ester (Compound No. C9 of Table C) FF F0 0 0 O F
K
2
CO
3 , KI N (N F II- F -FC C0 CI N N O C N N 0 H F 2-Fluoroethyl bromide was added to a mixture of 2,2-dimethyl-propionic acid 7 (2-chloro-3,6-difluoro-phenyl)-6-oxo-5,6-dihydro-pyrido[2,3-b]pyrazin-8-yl ester 20 (Example 1.3) (0.20 g), potassium carbonate (0.207 g) and potassium iodide (catalytic amount) in N,N-dimethylformanide (10 ml). The reaction mixture was heated in the WO 2008/071918 PCT/GB2007/004662 microwave for 20 minutes at 120'C. The reaction mixture was concentrated and the residue was purified by column chromatography on silica gel (eluent: ethyl acetate / hexane 1:1) to give Compound No. C9 of Table C as a yellow solid (0.103 g). 5 Example 2.3: Preparation of 2,2-dimethyl-propionic acid 7-(2-chloro-3,6-difluoro phenvl)-5-(2,2,2-trifluoro-ethyl)-6-oxo-5,6-dihydro-pyrido[2,3-blpyrazin-8-vl ester (Compound No. C8 of Table C) 1. F 3 C OSO 2
CF
3 O O F
K
2 C0 3 O O F [N F 2. F N N 0 N N 0 pyridine F 3 C A mixture of 2,2-dimethyl-propionic acid 7-(2-chloro-3,6-difluoro-phenyl)-6 10 oxo-5,6-dihydro-pyrido[2,3-b]pyrazin-8-yl ester (is this correct or did the reaction start with the unprotected species ) (Example 1.3) (0.10 g), potassium carbonate (0.053 g) and 2,2,2-trifluoroethyl triflate (0.130 g) were heated in a microwave at 150 0 C for 30 minutes, and then at 170'C for 30 minutes. The reaction mixture was allowed to cool to ambient temperature and was then partitioned between dichloromethane and aqueous 15 hydrochloric acid (2M). The phases were separated. The organic layer was dried over magnesium sulfate and concentrated. The residue was dissolved in dichloromethane and treated with trimethylacetyl chloride (0.063 ml) and pyridine (0.061 ml) and stirred at ambient temperature. The reaction mixture was concentrated and the residue was purified by column chromatography on silica gel (eluent: acetone / iso-hexane 0:10 to 1:9) to give 20 Compound No. C8 of Table C as a beige solid (0.049 g).
WO 2008/071918 PCT/GB2007/004662 Example 2.4: Preparation of 7-(2-chloro-3,6-difluoro-phenvl)-5-(2,2-difluoro-ethyl)-8 hydroxy-5H-pyrido[2,3-blpyrazin-6-one (Compound No. B2 of Table B) Br OH F F F 0' 0 K 2 00 3 , KI (N1-"F (N C1 F N O C1 N N O F H F 1-Bromo-2,2-difluoroethane (0.754 g) was added to a mixture of 2,2-dimethyl 5 propionic acid 7-(2-chloro-3,6-difluoro-phenyl)-6-oxo-5,6-dihydro-pyrido[2,3-b]pyrazin-8 yl ester (Example 1.3) (1.00 g), potassium carbonate (1.76 g) and potassium iodide (catalytic amount) in anhydrous NN-dimethylformamide (15 ml). The reaction mixture was heated in a microwave for 20 minutes at 120'C. The reaction mixture was allowed to cool to ambient temperature before diluting with water and ethyl acetate. The phases were separated. The 10 organic phase was washed with water, dried over magnesium sulfate, and concentrated. The residue was dissolved in diethyl ether, and the solution was washed with water. The phases were separated and the organic phase was concentrated to give Compound No. B2 of Table B as an orange viscous oil (0.553 g). 15 The compounds mentioned in Tables A to D below can be prepared using analogous methods to those described in Example 2.1, 2.2., 2.3 and 2.4. 3. Reactions which are covered by Scheme 3 Example 3.1: Preparation of 3-[2-(2,3,6-trichloro-phenvl)-acetylaminol-pyrazine-2 20 carboxylic acid N CO 2 Me N CO 2 H LiHMDS CN 11NH C N' NH O CI NO CI CI Cl Lithium hexamethyldisilazide ("LiHMDS") (1M in THF) (2 ml) was added dropwise to a solution of 3-[2-(2,3,6-trichloro-phenyl)-acetylamino]-pyrazine-2 carboxylic acid methyl ester (0.373 g) (which was made as described in Example 1.1) in WO 2008/071918 PCT/GB2007/004662 anhydrous tetrahydiofuran (10 ml). The reaction mixture was stirred for 30 minutes at ambient temperature and then heated to reflux for three hours. The reaction mixture was allowed to cool to ambient temperature and acidified by addition of aqueous hydrochloric acid (IM). The mixture was concentrated. The residue was dissolved in diethyl ether and 5 washed with aqueous hydrochloric acid (1M). The acid solution was extracted with ethyl acetate. The combined organic fractions were dried over magnesium sulfate and concentrated to give 3-[2-(2,3, 6 -trichloro-phenyl)-acetylamino]-pyrazine-2-carboxylic acid (0.225 g) which was carried on to the next step without further purification. 10 Example 3.2: Alternative preparation of 5-(2,2-difluoro-ethyl)-8-hydroxy-7-(2,3.6 trichloro-phenvl)-5H-pyrido[2,3-blpyrazin-6-one (Compound No. BI1 of Table B) N CO 2 H F OSO 2
CF
3 OH C1 F CI NaHMDS N < CI N NH C1 O IN N 0 0 "' CI F CI F Sodium hexamethyldisilazide ("NaHMDS") (IM in THF) (1.4 ml) was added dropwise to a solution of 3-[2-(2,3,6-trichloro-phenyl)-acetylamino]-pyrazine-2 15 carboxylic acid (Example 3.1) (0.225 g) in anhydrous tetrahydrofuran (10 ml) over a period of 10 minutes. Then difluoroethyl triflate (0.270 g) was added dropwise and the reaction mixture was allowed to stir at ambient temperature for 30 minutes. Then the reaction mixture was heated to reflux for 6 hours. The reaction mixture was allowed to cool to ambient temperature and acidified by addition of aqueous hydrochloric acid (IM). 20 The mixture was concentrated. The residue was dissolved in diethyl ether and washed with aqueous hydrochloric acid (1 M). The acid solution was extracted with ethyl acetate. The combined organic fractions were dried over magnesium sulfate and concentrated. The residue was purified by reverse phase HPLC to give Compound No. B 11 of Table B (0.034 g). 25 WO 2008/071918 PCT/GB2007/004662 4. Reactions which are covered by Scheme 10 Example 4.1: Preparation of 1-bromo-3-bromomethyl-2-chloro-4-fluoro-benzene
CH
3 Br Cl F NBS CI F Br Br A mixture of 3-bromo-2-chloro-6-fluoro-toluene (8.0 g), N-bromosuccinimide 5 ("NBS") (6.42 g) and benzoyl peroxide (catalytic amount) in carbon tetrachloride (40 ml) was heated to reflux. A 500 watt tungsten halogen lamp was used to initiate the reaction. The reaction mixture was heated to reflux and irradiated for 30 minutes. The reaction mixture was allowed to cool to ambient temperature and then filtered. The filtrate was concentrated to give a colourless oil which solidified on standing to give 1 -bromo-3 10 bromomethyl-2-chloro-4-fluoro-benzene as an off-white solid (10.7 g). 'H-NMR (400 MHz, CDCl 3 ): 4.64 (d, 2H), 6.94 (t, 1H), 7.58 (dd, 1H) ppm. Example 4.2: Preparation of (3-bromo-2-chloro-6-fluoro-phenyl)-acetonitrile Br CN C1 F KCN Cl F Br Br 15 A solution of 1-bromo-3-bromomethyl-2-chloro-4-fluoro-benzene (9.945 g) (Example 4.2) in absolute ethanol (40 ml) was added dropwise to a solution of potassium cyanide (2.38 g) in water (2 ml) under heating over a period of 30 minutes. The reaction mixture was heated to reflux for 7 hours. The reaction mixture was then allowed to cool to ambient temperature and then stored at ambient temperature for 16 hours. The mixture 20 was filtered and the filtrate concentrated. The residue was dissolved in ethyl acetate, dried over magnesium sulfate and concentrated to give (3-bromo-2-chloro-6-fluoro phenyl)-acetonitrile as a pale yellow oil (8.19 g). 1 H-NMR (400 MHz, CDCl 3 ): 3.89 (d, 2H), 7.00 (t, 1H), 7.64 (dd, 1H) ppm.
WO 2008/071918 PCT/GB2007/004662 Example 4.3: Preparation of (3-bromo-2-chloro-6-fluoro-phenyl)-acetic acid CN
CO
2 H CI F H 2 S C F Br Br (3-Bromo-2-chloro-6-fluoro-phenyl)-acetonitrile (8.15 g) (Example 4.3) was dissolved in concentrated sulfuric acid (50% by weight in water) (90 ml). The reaction 5 became very hot and was then heated to reflux for 3 hours. The reaction mixture was allowed to cool to ambient temperature and was stored at ambient temperature for 16 hours. The mixture was extracted twice with dichloromethane. The combined organic phases were dried over magnesium sulfate and concentrated to give (3-bromo-2-chloro 6-fluoro-phenyl)-acetic acid as an off-white solid (8.3 g). 'H-NMR (400 MHz, CDCl 3 ): 10 3.94 (d, 2H), 6.94 (t, 1H), 7.56 (dd, 1H) ppm. 5. Reactions which are covered by Scheme 12 Example 5.1: Preparation of 3-amino-6-methyl-pyrazine-2-carboxylic acid methyl ester
H
3
C-B(OH)
2 , Br N CO 2 Me Pd(OAc) 2 , H3C N C02Me S-Phos,
K
3 PO4 NX NH 2 NH 2 15 3-Amino-6-bromo-pyrazine-2-carboxylic acid methyl ester (1.0 g) (made according to J. Org. Chem. (1988), 59(9), 2052-5), palladium(II) acetate (0.101 g), and 2'-dicyclohexylphosphino-2,6-dimethoxy-1,1'-biphenyl ("S-Phos") were placed in a flask with toluene (15 ml) and water (3 drops). Methyl boronic acid (0.3 94 g) and potassium phosphate (1.71 g) were added and the reaction mixture was heated to reflux for 24 20 hours. After allowing the reaction mixture to cool to ambient temperature, the mixture was diluted with aqueous hydrochloric acid (IM) and extracted with ethyl acetate. The combined organic extracts were concentrated and the residue was purified by column chromatography on silica gel (eluent: diethyl ether) to give 3-amino-6-methyl-pyrazine 2-carboxylic acid methyl ester as a yellow solid (0.114 g). 'H-NMR (400 MHz, CDCl 3 ): 25 2.40 (s, 3H), 3.92 (s, 3H), 6.21 (bs, 2H), 8.03 (s, 1H) ppm.
WO 2008/071918 PCT/GB2007/004662 Table A: Compounds of formula (Ia"), i.e. compounds of formula (I) wherein R 3 is 2,2-difluoro ethyl, and R', R 2 , R 4 and R have the values as defined in the table below.
R
5 RR4 N(la") R N N 0 F F Compound R R- R4 R H-NMR (400 MHz, No CDC13 unless indicated -il---i-F3C- -tBu- otherwise) Al H H 2-F 3 CO- t-Bu- 1.19 (s, 9H), 4.98 (dt, 2H), phenyl- (CO)O- 6.25 (tt, 1H), 7.33-7.40 (m, 3H), 7.47-7.51 (m, 1H), 8.54 (d, 1H), 8.59 (d, 1H). A2 H H 2-Cl-3,6- t-Bu- 1.21 (s, 9H), 4.98 (dt, 2H), di-F- (CO)O- 6.27 (tt, 1H), 7.07-7.13 (in, phenyl- 1H), 7.21-7.27 (m, 1H), 8.57 (d, 1H), 8.62 (d, 1H). A3 H H 2-Cl-3,6- i-Pr- 1.17 (dd, 6H), 2.81 (sept, di-F- (CO)O- 1H), 4.98 (dt, 2H), 6.26 (tt, phenyl- 1H), 7.08-7.14 (m, 1H), 7.21-7.28 (m, 1H), 8.58 (d, 1H), 8.63 (d, 1H). A4 H H 2-Cl-3- i-Pr- 1.10 (d, 6H), 2.72 (d, 3H),
F
3 C- (CO)O- 5.02 (in, 1H), 6.01-6.40 (tt, phenyl- 1H), 7.37 (m, 1H), 7.60 (m, 1H), 8.58 (d, 1H), 8.62 (d, 1H). A5 H H 2-Cl-6- t-Bu- 1.17 (s, 9H), 2.27 (d, 3H), F-5-Me- (CO)O- 3.87 (s, 3H), 7.19 (in, 2H), phenyl- 8.49 (d, 1H), 8.58 (d, 1H). A6 H H 2-C1-6- i-Pr- 1.10 (d, 3H), 1.11 (d, 3H), F-5-Me- (CO)O- 2.27 (d, 3H), 2.77 (sept, phenyl- 1H), 3.86 (s, 3H), 7.19 (d, 2H), 8.49 (d, 1H), 8.59 (d, 1H). A7 H H 2-Cl-5- i-Pr- 1.07 (d, 3H), 1.14 (d, 3H),
F
3 C- (CO)O- 2.76 (sept, 1H), 4.97 (dt, phenyl- 2H), 6.25 (tt, 1H), 7.56 (s, 1H), 7.65 (d, 2H), 8.56 (d, 1H), 8.61 (d, 1H).
WO 2008/071918 PCT/GB2007/004662 Compound Ri R2 R4 R 'H-NMR (400 MHz, No CDC1 3 unless indicated otherwise) A8 H H 2-C1-5- t-Bu- 1.16 (s, 9H), 4.97 (dt, 2H),
F
3 C- (CO)O- 6.25 (tt, 1H), 7.56 (s, 1H), phenyl- 7.64 (m, 2H), 8.56 (d, 1H), - 8.61 (d, 1H). A9 H H 2,6-di- t-Bu- 1.12 (s, 9H), 4.98 (m, 2H), Cl-4- (CO)O- 6.20 (tt, 1H), 7.68 (s, 2H),
F
3 C- 8.55 (d, 1H), 8.60 (d, 1H). phenyl AlO H H 2-Br-4- t-Bu- 1.16 (s, 9H), 4.94-5.02 (dt,
F
3 C- (CO)O- 2H), 6.11-6.42 (tt, 1H), phenyl- 7.40-7.42 (d, 1H), 7.65 7.67 (dd, 1H), 7.97 (d, 1H), 8.48-8.49 (d, 1H), 8.51-8.52 (d, 1H). All H H 2,6-di- t-Bu- 1.20 (s, 9H), 4.96 (m, 2H), C1-4- (CO)O- 6.22 (tt, 1H), 7.31 (m, 1H),
F
3 CO- 7.48 (d, 1H), 8.55 (d, 1H), phenyl- 8.60 (d, 1H). A12 H H 2,6-di- i-Pr- 1.00 (d, 6H), 1.10 (t, 6H), Et-4-Me- (CO)O- 2.34-2.42 (m, 4H), 2.36 (s, phenyl- 3H), 2.63-2.73 (m, 1H), 4.98 (dt, 2H), 6.25 (tt, 1H), 6.99 (s, 2H), 8.52 (d, 1H), 8.57 (d, 1H). A13 H H 2-CJ-5- i-Pr- 1.1 (d, 3H), 1.16 (d, 3H), F- (CO)O- 2.79 (sept, 1H), 4.57 (dt, phenyl- 2H), 6.25 (tt, 1H), 7.03 (dd, 1H), 7.11 (m, 1H), 7.46 (dd, 1H), 8.55 (d, 1H), 8.60 (d, 1H). A14 H H 2-C1-5- t-Bu- 1.18 (s, 9H), 4.96 (dt, 2H), F- (CO)O- 6.25 (tt, 1H), 7.03 (dd, phenyl- 1H), 7.10 (m, 1H), 7.47 (dd, 1H), 8.55 (d, 1H), 8.59 (d, 1H). A15 H H1 2,3-di- i-Pr- 1.09 (d, 3H), 1.14 (d, 3H), MeG- (CO)O- 2.75 (sept, 1H), 3.79 (s, phenyl- 3H), 3.89 (s, 3H), 4.95 (m, 2H), 6.25 (tt, 1H), 6.78 (d, 1H), 6.99 (dd, 1H), 7.09 (t, 1H), 8.50 (d, 1H), 8.54 (d, 1H). A16 H H 2,3-di- t-Bu- 1.16 (s, 9H), 3.78 (s, 3H), MeO- (CO)O- 3.88 (s, 3H), 4.95 (m, 2H), phenyl- 6.25 (tt, 1H), 6.77 (d, 1H), 6.98 (dd, 1H), 7.08 (t, 1H), 8.50 (d, 1H), 8.53 (d, 1H).
WO 2008/071918 PCT/GB2007/004662 Compound R' |R R4 R | 'H-NMR (400 MHz, No CDCl 3 unless indicated otherwise) A17 H H 2,4-di- t-Bu- 1.22 (s, 9H), 4.95 (dt, 2H), Cl-5-F- (CO)O- 6.24 (tt, 1H), 7.12 (d, 1H), phenyl- 7.58 (d, 1H), 8.56 (d, 1H), 8.60 (d, 1H). A19 H H 3-Br-2- t-Bu- 1.19 (s, 9H), 4.97 (dt, 2H), Cl-6-F- (CO)O- 6.24 (tt, 1H), 7.02 (t, 1H), phenyl- 7.70 (d, 1H), 8.56 (d, 1H), 8.60 (d, 1H). A20 H H 2,4-di- i-Pr- 1.15 (d, 3H), 1.20 (d, 3H), Cl-5-F- (CO)O- 2.81 (sept, 1H), 4.95 (dt, phenyl- 2H), 6.24 (tt, 1H), 7.11 (d, 1H), 7.58 (d, 1H), 8.56 (d, 1H), 8.61 (d, 1H). A21 H H 3-Br-2- i-Pr- 1.14 (d, 3H), 1.15 (d, 3H), Cl-6-F- (CO)O- 2.79 (sept, 1H), 4.96 (dt, phenyl- 2H), 6.24 (tt, 1H), 7.02 (t, 1H), 7.70 (dd, 1H), 8.56 (d, 1H), 8.61 (d, 1H). A22 H H 2,4,6-tri- i-Pr- 1.00 (d, 6H), 2.07 (s, 6H), Me- (CO)O- 2.29 (s, 3H), 2.68 (sept, phenyl- 1H), 4.97 (dt, 2H), 6.25 (tt, 1H), 6.91 (s, 2H), 8.53 (d, 1H), 8.57 (d, 1H). A23 H H 2-MeO- i-Pr- 1.10 (d, 3H), 1.15 (d, 3H), 5-F 3 CO- (CO)O- 2.76 (sept, 1H), 3.83 (s, phenyl- 3H), 4.95 (m, 2H), 6.25 (tt, 1H), 7.06 (d, 1H), 7.48 (s, 1H), 7.67 (dd, 1H), 8.52 (d, 1H), 8.57 (d, 1H). A25 H H 2,4,6-tri- t-Bu- 1.07 (s, 9H), 2.08 (s, 6H), Me- (CO)O- 2.28 (s, 3H), 4.98 (dt, 2H), phenyl- 6.26 (tt, 1H), 6.91 (s, 2H), 8.52 (d, 1H), 8.55 (d, 1H). A26 H H 2- i-Pr- 1.13 (d, 3H), 1.17 (d, 3H),
F
2 HCO- (CO)O- 2.78 (sept, 1H), 4.95 (in, phenyl- 2H), 6.23 (tt, 1H), 6.46 (dd, 1H), 7.29 (m, 3H), 7.46 (in, 1H), 8.53 (d, 1H), 8.57 (d, 1H). A27 H H 2-MeO- t-Bu- 1.17 (s, 9H), 3.83 (s, 3H), 5-F 3 CO- (CO)O- 4.95 (m, 2H), 6.25 (tt, 1H), phenyl- 7.05 (d, 1H), 7.48 (s, 1H), 7.67 (dd, 1H), 8.52 (d, 1H), 8.56 (d, 1H).
WO 2008/071918 PCT/GB2007/004662 Compound R' R2 R R - 5 H-NMR (400 MHz, No CDCl 3 unless indicated otherwise) A28 H H 2- t-Bu- 1.19 (s, 9H), 4.95 (in, 2H),
F
2 HCO- (CO)O- 6.23 (tt, 1H), 6.46 (dd, phenyl- 1H), 7.29 (m, 3H), 7.45 (m, 1H), 8.53 (d, 1H), 8.57 (d, 1H). A29 -Me H 2-Cl-3,6- t-Bu- 1.25 (s, 9H), 2.65 (s, 3H), di-F- (CO)O- 4.90-4.50 (in, 2H), 6.10 phenyl- 6.40 (in, 1H), 7.10 (m, 1H), 7.25 (m, 1H), 8.50 (s, 1H). A30 H -Me 2-Cl-3,6- t-Bu- 1.20 (s, 9H), 2.70 (s, 3H), di-F- (CO)O- 5.00 (m, 2H), 6.10-6.40 phenyl- (m, 1H), 7.10 (m, 1H), 7.25 (m, 1H), 8.40 (s, 1H). A31 -Ph H 2-Cl-3,6- t-Bu- 1.25 (s, 9H), 5.00 (m, 2H), di-F- (CO)O- 6.15-6.40 (m, 1H), 7.10 phenyl- (m, 1H), 7.25 (in, 1H), 7.50 (m, 3H), 8.00 (d, 2H), 9.05 (s, 1H). A32 H H 2,3-di- t-Bu- 1.18 (s, 9H), 4.92-5.02 (m, Cl-6-F- (CO)O- 2H), 6.25 (tt, 1H), 7.08 (t, phenyl- 1H), 7.55 (dd, 1H), 8.55 (d, 1H), 8.62 (d, 1H). A33 H H 2-Cl-4,5- t-Bu- 1.22 (s, 9H), 2.95 (m, 2H), di-F- (CO)O- 6.35 (tt, 1H), 7.15 (dd, phenyl- 1H), 7.30 (dd, 1H), 8.55 (d, 1H), 8.62 (d, 1H). A34 H H 2-C1-6- t-Bu- 1.20 (s, 9H), 5.01 (in, 2H), F- (CO)O- 6.35 (tt, 1H), 7.04 (m, 1H), phenyl- 7.32-7.41 (m, 2H), 8.53 (d, 1H), 8.60 (d, 1H). A35 H -Me 2,6-di- t-Bu- 1.18 (s, 9H), 2.71 (s, 3H), Cl-4- (CO)O- 5.00 (m, 2H), 6.15-6.37
F
3 C- (m, 1H), 7.10 (m, 1H), I phenyl- 7.68 (s, 2H), 8.45 (s, 1H). A36 H H 2-I- t-Bu- 1.15 (s, 9H), 5.02 (m, 2H), phenyl- (CO)O- 6.37 (tt, 1H), 7.08 ddd, 1H), 7.20 (dd, 1H), 7.41 (ddd, 1H), 7.96 (dd, 1H), 8.52 (d, 1H), 8.60 (d, 1H). A37 H H 5-C1-2- t-Bu- 1.12 (s, 9H), 4.94 (in, 2H),
F
3 C- (CO)O- 6.22 (tt, 1H), 7.30 (s, 1H), phenyl- 7.53 (d, 1H), 7.73 (d, 1H), 8.55 (d, 1H), 8.60 (d, 1H).
WO 2008/071918 PCT/GB2007/004662 Compound R1 R 4 Ra 5 H-NMR (400 MHz, No CDC1 3 unless indicated otherwise) A38 H H 5-Br-2- t-Bu- 1.21 (s, 9H), 3.76 (s, 3H), MeO- (CO)O- 4.94 (m, 2H), 6.24 (tt, 1H), phenyl- 6.87 (d, 1H), 7.31 (s, 1H), 7.49 (dd, 1H), 8.51 (d, 1H), 8.54 (d, 1H). A41 H H 2-Cl-6- i-Pr- 1.03 (d, 3H), 1.08 (d, 3H),
F
3 C- (CO)O- 2.72 (sept, 1H), 4.96 (m, phenyl- 2H), 6.22 (t, 1H), 7.52 (t, 1H), 7.71 (d, 2H), 8.55 (d, 1H), 8.60 (d, 1H). A42 H H 2,5-di- t-Bu- 1.19 (s, 9H), 4.96 (dt, 2H), Cl- (CO)O- 6.25 (tt, 1H), 7.28 (d, 1H), phenyl- 7.35 (dd, 1H), 7.44 (d, 1H), 8.56 (d, 1H), 8.59 (d, 1H). A43 H H 2,5-di- t-Bu- 1.08 (s, 9H), 4.95 (m, 2H),
F
3 C- (CO)O- 6.22 (tt, 1H), 7.58 (s, 1H), phenyl- 7.84 (d, 1H), 7.94 (d, 1H), 8.56 (d, 1H), 8.61 (d, 1H). A44 H H 4,5-di-F- t-Bu- 1.22 (s, 9H), 3.74 (s, 3H), 2-MeO- (CO)O- 4.94 (m, 2H), 6.23 (tt, 1H), phenyl- 6.81 (dd, 1H), 7.07 (t, 1H), 8.51 (d, 1H), 8.55 (d, 1H). A45 H H 2-Et- i-Pr- 1.01 (d, 3H), 1.06 (d, 3H), phenyl- (CO)O- 1.16 (t, 3H), 2.40-2.59 (m, 2H), 2.67-2.74 (m, 1H), 4.91-5.02 (m, 2H), 6.26 (tt, 1H), 7.11 (d, 1H), 7.21 7.26 (m, 1H), 7.34-7.39 (m, 2H), 8.54 (d, 1H), 8.59 (d, 1H). A46 H H 2,3-di- i-Pr- 1.08 (d, 3H), 1.15 (d, 3H), Cl- (CO)O- 2.76 (m, 1H), 4.95 (dt, phenyl- 2H), 6.25 (tt, 1H), 7.19 (dd, 1H), 7.28 (t, 1H), 7.54 (dd, 1H), 8.55 (d, 1H), 8.60 (d, 1H). A47 H H 2-Cl-6- t-Bu- 1.10 (s, 9H), 4.97 (m, 2H),
F
3 C- (CO)O- 6.22 (tt, 1H), 7.51 (t, 1H), phenyl- 7.71 (d, 2H), 8.55 (d, 1H), 8.60 (d, 1H). A48 H H 2,3-di- i-Pr- 1.20 (m, 6H), 2.82 (in, Cl-6-F- (CO)O- 1H), 4.98 (m, 2H), 6.12 (tt, phenyl 1H), 7.03 (t, 1H), 7.50 (m, 1H), 8.52 (d, 1H), 8.60 (d, 1H).
WO 2008/071918 PCT/GB2007/004662 Ke3: s = singlet; d = doublet; t = triplet; dd = double doublet; ddd = double double doublet; dt = double triplet; tt = triple triplet; q = quartet; sept = septet; m = multiplet; Me = methyl; Et = ethyl; Pr = propyl; Bu = butyl; Ph = phenyl. 5 Table B: Compounds of fonnula (Ib"), i.e. compounds of formula (I) wherein R 1 and R 2 are hydrogen, R3 is 2,2-difluoro-ethyl, R5 is hydroxy, and R 4 has the values as defined in the table below. OH H N I (Ib") H N N 0 F 10 F Compound RH-NMR (400 MHz, No CDC1 3 unless indicated otherwise) B1 2-C1-3- 5.00 (i, 2H), 6.30 (tt, 1K),
F
3 C- 7.05 (in, 2H), 7.21 (in, phenyl- 1H), 8.60 (d, 1H), 8.78 (d, 1K). B2 2-C1-3,6- 4.92 (dt, 2H), 6.09-6.40 (tt, di-F- 1H), 7.08-7.14 (in, 2H), phenyl- 7.16-7.26 (i, 2H), 8.52 (d, 1K), 8.72 (d, 1H). B3 2-Cl-5- 4.92 (in, 2H), 6.94 (tt, 1K),
F
3 C- 7.59-7.67 (i, 3H), 8.51 (d, phenyl- lH), 8.71 (d, 1K). B4 2,6-di- 1.00 (d, 3K), 1.10 (t, 3K), Et-4-Me- 2.34-2.42 (in, 2K), 2.36 (s, phenyl- 3K), 2.63-2.73 (i, 1K), 4.98 (dt, 2K), 6.25 (tt, 1K), 6.99 (s, 2K), 8.52 (d, 1K), 8.57 (d, 1K). B5 2,4,6-tri- 2.11 (s, 6), 2.31 (s, 3K), Me- 4.92 (dt, 2K), 6.24 (tt, 1K), phenyl- 6.98 (s, 2K), 7.87 (s, 1K), _________ _______8.48 (d, 1K), 8.65 (d. 1K). B6 3-Br-2- 4.92 (dt, 2K), 6.23 (tt, 1K), Cl-6-F- 7.03 (t, 1K), 7.69 (dd, 1K), phenyl- 8.26 (s, 1H), 8.51 (d, 1H), 8.71 (d, 1H).
WO 2008/071918 PCT/GB2007/004662 Compound R4 'H-NMR (400 MHz, No CDC1 3 unless indicated otherwise) B7 2-C1-5- 4.91 (i, 2H), 6.24 (tt, IH), F- 7.10 (m, 2H), 7.48 (dd, phenyl- lH), 8.16 (s, 1H), 8.50 (d, lH), 8.69 (d, I1H). B8 2-MeO- 3.85 (s, 3H), 4.90 (m, 2H), 5-F 3 CO- 6.24 (f, 1H), 7.08 (d, lH), phenyl- 7.60 (s, 1H), 7.66 (d, 1H), 8.07 (s, 1H), 8.47 (d, 1H), 8.66 (d, 1H). B9 2-C1-6- (CD 3 OD): 4.80 (m, 2H), F-3- 6.18 (tt, 1H), 7.42 (i, 1H), 0 2 N- 8.03 (m, 1H), 8.62 (d, 1H), phenyl- 8.74 (d, IH). B1O 5-C1-2- 4.89 (dt, 2H), 6.20 (tt, 1H),
F
3 C- 7.37 (s, 1H), 7.52 (d, 1H), phenyl- 7.73 (d, 1H), 8.50 (d, 1H), 8.70 (d, 1H). B11 2,3,6-tri- (CD 3 D): 4.85 (m, 2H), Cl- 6.16 (in, 1H), 7.41 (d, 1H), phenyl- 7.48 (d, 1H), 8.55 (d, IH), 8.65 (d, I1H). B12 5-Br-2- 3.78 (s, 3H), 4.90 (m, 2H), MeO- 6.23 (tt, 1H), 6.90 (d, 1H), phenyl- 7.44 (d, 1H), 7.49 (dd, 1H), 8.47 (d, 1H), 8.65 (d, 1H). B13 2-Cl-6- 4.96 (dt, 2H), 6.20 (tt, 1H),
F
3 C- 7.51 (t, 11), 7.73 (d, 2H), phenyl- 8.50 (d, 1H), 8.70 (d, 1H). B14 2,3-di- 4.92 (2H, i), 6.25 (1H, Cl-6-F- i), 7.20 (1H, dd), 7.53 phenyl- (1H, dd), 8.52 (1H, d), 8.71 (14H, d). B15 2,3-di- 4.91 (m, 2H), 6.24 (tt, 1H), Cl- 7.31 (m, 2H), 7.54 (in, phenyl- 1H), 8.50 (d, 1H), 8.69 (d, 8H). s = singlet; d = doublet; t =triplet; dd = double doublet; dt =double triplet; tt triple triplet; in = inultiplet; Me =methyl; Et = ethyl. 5 WO 2008/071918 PCT/GB2007/004662 Table C: Compounds of formula (Ia'), i.e. compounds of formula (I) wherein R 1 and R 2 are hydrogen, and R, R 4 and R 5 have the values as defined in the table below. H N (la') H N N 0 13 R Com- R7 R4 R5 'H-NMR (400 MHz, pound CDCl 3 unless indicated No otherwise) C1 4-chloro- 2-F 3 CO- t-Bu- 1.17 (s, 9H), 1.83-2.00 (m, butyl- phenyl- (CO)O- 4H), 3.57-3.63 (m, 2H), 4.52-4.60 (m, 2H), 7.3 1 7.40 (m, 3H), 7.42-7.49 (m, 1H), 8.48 (d, 1H), 8.56 (d, 1H). C2 3,3,3- 2-F 3 CO- t-Bu- 1.17 (s, 9H), 2.56-2.69 (m, trifluoro- phenyl- (CO)O- 2H), 4.74-4.87 (m, 2H), propyl- 7.30-7.41 (m, 3H), 7.43 7.50 (in, 1H), 8.51 (d, 1H), 8.59 (d, 1H). C3 4,4,4,3,3 2-F 3 CO- t-Bu- 1.18 (s, 9H), 2.50-2.66 (m, phenyl- (CO)O- 2H), 4.80-4.93 (m, 2H), pentafluo 7.33-7.41 (m, 3H), 7.44 ro-butyl- 7.51 (m, 1H), 8.52 (d, 1H), 8.60 (d, 1H). C4 4-chloro- 2-C1-3,6- t-Bu- 1.24 (s, 9H), 1.90-2.04 (m, butyl- di-F- (CO)O- 4H), 3.64 (t, 2H), 4.60 (t, phenyl- 2H), 7.09-7.16 (m, 1H), 7.22-7.29 (in, 1H), 8.56 (d, 1H), 8.64 (d, 1H). C5 3-chloro- 2-Cl-3,6- t-Bu- 1.24 (s, 9H), 2.29-2.38 (m, propyl- di-F- (CO)O- 2H), 3.69 (t, 2H), 4.72 (t, phenyl- 2H), 7.09-7.16 (m, 1H), 7.22-7.29 (m, 1H), 8.57 (d, 1H), 8.65 (d, 1H). C6 3,3,3- 2-C1-3,6- t-Bu- 1.21 (s, 9H), 2.59-2.71 (m, trifluoro- di-F- (CO)O- 2H), 4.79-4.86 (m, 2H), propyl- phenyl- 7.07-7.13 (m, 1H), 7.20 7.27 (in, 1H), 8.57 (d, 1H), 8.63 (d, 1H). C7 4,4,4,3,3 2-Cl-3,6- t-Bu- 1.21 (s, 9H), 2.53-2.68 (m, di-F- (CO)O- 2H), 4.84-4.90 (in, 2H), pentafluo phenyl- 7.07-7.14 (m, 1H), 7.21 ro-butyl- 7.27 (in, 1H), 8.58 (d, 1H), 8.64 (d, 1H).
WO 2008/071918 PCT/GB2007/004662 Com- R' R R 1 H-NMR (400 MHz, pound CDC1 3 unless indicated No otherwise) C8 2,2,2- 2-Cl-3,6- t-Bu- 1.21 (t, 9H), 5.28 (q, 2H), trifluoro- di-F- (CO)O- 7.07-7.28 (m, 2H), 8.58 ethyl- phenyl- (m, 1H), 8.61 (m, 1H). C9 2-fluoro- 2-C1-3,6- t-Bu- 1.21 (s, 9H), 4.77 (t, 1H), ethyl- di-F- (CO)O- 4.87-4.93 (m, 2H), 4.94 phenyl- 4.99 (m, 1H), 7.06-7.12 (m, 1H), 7.20-7.26 (m, 1H), 8.53 (d, 1H), 8.61 (d, 1H). Clo 2,2,2- 2-Cl-3,6- i-Pr- 1.16-1.17 (d, 6H), 2.78 trifluoro- di-F- (CO)O- 2.85 (m, 1H), 5.25-5.31 ethyl- phenyl- (m, 2H), 7.07-7.12 (m, 1H), 7.21-7.26 (m, 1H), 8.58 (d, 1H), 8.62 (d, 1H). C1l 4,4- 2-Cl-3,6- t-Bu- 1.20 (s, 9H), 2.51 (q, 2H), difluoro- di-F- (CO)O- 4.21-4.32 (m, 1H), 4.59 (t, but-3-en- phenyl- 2H), 7.06-7.12 (m, 1H), 1-yl- 7.19-7.27 (m, 1H), 8.52 (d, 1H), 8.60 (d, 1H). C12 3,4,4- 2-C1-3,6- t-Bu- 1.20 (s, 9H), 2.78-2.89 (m, trifluoro- di-F- (CO)O- 2H), 4.79 (t, 2H), 7.06 but-3-en- phenyl- 7.12 (in, 1H), 7.19-7.27 1-yl- (m, 1H), 8.54 (d, 1H), 8.62 (d, 1H). C13 3,3- 2-C1-3,6- t-Bu- 1.21 (s, 9H), 5.28 (d, 2H), dichloro- di-F- (CO)O- 6.06 (t, 1H), 7.06-7.12 (m, prop-2- phenyl- 1H), 7.19-7.26 (m, 1H), en-1-yl- 8.55 (d, 1H), 8.62 (d, 1H). C14 3,3- 2-C1-3,6- i-Pr- 1.17 (dd, 6H), 2.80 (sept, dichloro- di-F- (CO)O- 1H), 5.28 (d, 2H), 6.07 (t, prop-2- phenyl- 1H), 7.07-7.12 (m, 1H), en-1-yl- 7.20-7.26 (m, 1H), 8.55 (d, 1H), 8.63 (d, 1H). C15 2-fluoro- 2-C1-3,6- t-Bu- 1.20 (s, 9H), 4.47 (dd, prop-2- di-F- (CO)O- 1H), 4.76 (dd, 1H), 5.29 en-1-yl- phenyl- (d, 2H), 7.05-7.12 (in, 1H), 7.19-7.25 (m, 1H), 8.55 (d, 1H), 8.61 (d, 1H). C16 2-fluoro- 2-C1-3,6- i-Pr- 1.17 (dd, 6H), 2.81 (sept, prop-2- di-F- (CO)O- 1H), 4.49 (dd, 1H), 4.77 en-1-yl- phenyl- (dd, 1H), 5.29 (d, 2H), 7.06-7.12 (m, 1H), 7.20 7.26 (m, 1H), 8.55 (d, 1H), 8.62 (d, 1H).
WO 2008/071918 PCT/GB2007/004662 Com- R3 R7 P H-NMR (400 MHz, pound CDCl 3 unless indicated No otherwise) C17 2-chloro- 2-C1-3,6- i-Pr- 1.17 (dd, 6H), 2.81 (sept, prop-2- di-F- (CO)O- 1H), 5.20 (d, 1H), 5.32 (s, en-1-yl- phenyl- 2H), 5.35 (d, 1H), 7.06 7.12 (in, 1H), 7.19-7.26 (in, 1H), 8.55 (d, 1H), 8.62 (d, 1H). C18 3,3- 2-Cl-3,6- i-Pr- 1.17 (dd, 6H), 2.81 (sept, difluoro- di-F- (CO)O- 1H), 4.57-4.67 (in, 1H), prop-2- phenyl- 5.17 (d, 2H), 7.06-7.12 (in, en-1-yl- 1H), 7.20-7.25 (in, 1H), 8.53 (d, 1H), 8.62 (d, 1H). Key: s = singlet; d = doublet; t = triplet; dd = double doublet; q = quartet; sept = septet; in= multiplet; Pr = propyl; Bu = butyl. 5 Table D: Compounds of formula (Ib'), i.e. compounds of formula (I) wherein R 1 and R 2 are hydrogen, R 5 is hydroxy, and R 3 and R 4 have the values as defined in the table below. 0 (Ib') H N N 0 13 R Com- R 3 R4 'H-NMR (400 MHz, CDC13 pound No unless indicated otherwise) D1 2,2,2- 2-Cl-3,6- 5.27-5.34 (in, 2H), 7.21-7.26 trifluoro- di-F- (m, 1H), 7.35-7.41 (in, 1H), ethyl- phenyl- 8.70 (d, 1H), 8.78 (d, 1H). D2 2-fluoro- 2-Cl-3,6- 4.74 (t, 1H), 4.83-4.88 (in, ethyl- di-F- 2H), 4.89-4.95 (in, 1H), 7.06 phenyl- 7.13 (in, 1H), 7.18-7.25 (in, 1H), 8.48 (d, 1H), 8.70 (d, 1H). D3 3,3- 2-Cl-3,6- (d 6 -DMSO): 5.02 (d, 2H), 6.19 dichloro- di-F- (t, 1H), 7.31-7.37 (in, 1H), prop-2-en- phenyl- 7.47-7.54 (in, 1H), 8.62 (d, 1-yl- 1H), 8.79 (d, 1H).
WO 2008/071918 PCT/GB2007/004662 Com- R' R4 'H-NMR (400 MHz, CDCl 3 pound No unless indicated otherwise) D4 3,3- 2-Cl-3,6- (d 6 -DMSO): 4.73-4.85 (m, difluoro- di-F- 1H), 4.98 (d, 2H), 7.36-7.42 prop-2-en- phenyl- (m, 1H), 7.53-7.60 (m, 1H), 1-yl- 8.69 (d, lH), 8.86 (d, 1H). d = doublet; t = triplet; m = multiplet. 5 Biological Examples Example B 1: Herbicidal action Seeds of a variety of test species were sown in sterilised standard soil in seed trays each having 96 cells. After cultivation for 8 to 9 days cultivation (post-emergence) 10 under controlled conditions in a climatic chamber (cultivation at 23/17-C, day/night; 13 hours light; 50-60% humidity), the plants were treated with an aqueous spray solution of 1000 mg/l of the active ingredient dissolved in 10% DMSO (dimethyl sulfoxide, CAS RN 67-68-5) as a solvent, equivalent to 1000 g/ha. The plants were grown in the climatic chamber after application at (24/19'C, day/night; 13 hours light; 50-60% humidity) and 15 watered twice daily. After 9 days until the test was evaluated (10 = total damage to plant, 0 = no damage to plant) Table B 1: Application post-emergence Comp No. Rate (g/ha) STEME NAAOF AMARE SOLNI 20 Al 1000 7 8 0 6 A2 1000 9 9 4 6 A3 1000 9 7 6 5 A5 1000 7 5 4 2 A6 1000 7 7 5 0 25 A7 1000 8 7 4 5 A8 1000 7 7 6 6 B1 1000 5 6 0 6 B2 1000 8 8 6 5 C2 1000 0 0 0 4 30 C4 1000 1 0 0 4 WO 2008/071918 PCT/GB2007/004662 C6 1000 3 0 0 1 C7 1000 0 0 0 3 STEME = Stellaria media; NAAOF = Nasturtium officinale; AMARE = Amaranthus retroflexus; SOLNI= Solanum nigrum. 5 Compound No. C1, C3 and C5 were tested using the same protocol and showed no damage or very little damage to the test plants under the test conditions. Example B2: Herbicidal action 10 Seeds of a variety of test species were sown in standard soil in pots. After 8 days cultivation (post-emergence) under controlled conditions in a glasshouse (at 24/16'C, day/night; 14 hours light; 65% humidity), the plants were sprayed with an aqueous spray solution derived from the formulation of the technical active ingredient in acetone / water (50:50) solution containing 0.5% Tween 20 (polyoxyethelyene sorbitan monolaurate, 15 CAS RN 9005-64-5). The test plants were then grown in a glasshouse under controlled conditions in a glasshouse (at 24/16'C, day/night; 14 hours light; 65% humidity) and watered twice daily. After 13 days, the test was evaluated (10 = total damage to plant; 0 = no damage to plant). 20 Table B2: Application post-emergence Comp No. Rate (g/ha) SOLNI AMARE SETFA ECHCG IPOHE A9 1000 10 10 9 7 A10 1000 9 10 3 4 5 All 1000 10 10 9 9 10 25 A12 1000 10 3 10 9 9 A13 1000 10 10 9 8 10 A14 1000 10 10 9 7 10 A15 1000 10 6 9 8 9 A16 1000 10 8 8 3 7 30 A17 1000 5 3 7 6 0 A19 1000 10 10 8 7 9 A20 1000 9 10 8 7 7 A23 1000 10 10 9 8 9 A25 1000 10 7 7 7 8 WO 2008/071918 PCT/GB2007/004662 A26 1000 5 10 2 2 5 A27 1000 9 9 7 7 7 A28 1000 10 9 3 1 8 A32 1000 10 10 7 4 9 5 A33 1000 10 10 7 4 7 A34 1000 10 10 6 4 9 A35 1000 5 0 5 3 2 A37 1000 5 6 7 5 7 A38 1000 9 10 8 6 6 10 A41 1000 10 10 9 8 9 A42 1000 10 10 7 6 9 A43 1000 9 10 9 8 9 A44 1000 10 9 9 7 6 A45 1000 10 10 8 5 9 15 B3 250 9 10 7 7 8 B4 1000 10 7 9 8 10 B5 1000 10 7 8 8 10 B6 1000 10 10 8 8 10 B7 1000 9 10 7' 7 9 20 B8 1000 9 10 9 9 9 B9 1000 9 9 7 8 8 B1-0 1000 10 10 9 9 10 Bl 1000 10 10 9 8 10 B12 1000 9 9 6 6 6 25 B13 1000 10 10 9 9 10 B14 1000 10 10 7 6 10 C8 1000 10 10 4 1 10 C9 1000 4 7 0 0 5 C1O 1000 10 10 6 3 10 30 C1I 1000 2 5 0 0 0 C12 1000 3 6 0 0 1 C13 1000 3 0 0 0 1 C14 1000 8 8 0 0 1 D1 1000 10 10 6 5 10 WO 2008/071918 PCT/GB2007/004662 D2 1000 7 6 2 1 5 D3 1000 7 9 3 0 7 SOLNI= Solanum nigrum; AMARE = Amaranthus retroflexus; SETFA = Setaria faberi; ECHCG = Echinochloa crus-galli; IPOHE = Ipomea hederaceae. 5 Compound No. A29, A30 and A31 were tested using the same protocol and showed no damage or very little damage to the test plants under the test conditions. Example B3: Herbicidal action Seeds of a variety of test species were sown in sterilised compost in small pots. 10 After cultivation for seven days (post-emergence) in controlled conditions in the glasshouse (at 24/16*C, day/night; 14 hours light; 65% humidity) the plants were sprayed with 1 mg of the active ingredient, formulated in 2.5ml acetone / water (50:50) solution, which is equivalent to 1000 g/ha. Once the foliage was dry, the pots were kept in the glasshouse (at 24/16'C, day/night; 14 hours light; 65% humidity), and were watered 15 twice daily. After 13 days the test was evaluated (10 = total damage to plant, 0 = no damage to plant). Table B3 . Application post-emergence Comp No. Rate (g/ha) AMARE ALOMY DIGSA CHEAL 20 A4 1000 10 0 7 10 A36 1000 10 8 5 10 AMARE = Amaranthus retroflexus; ALOMY = Alopecurus myosuroides; DIGSA Digitaria sanguinalis; CHEAL = Chenopodium album.

权利要求:
Claims (18)
[1] 1. A compound of formula (I) R 5 R4 N R 4 2() R N N 0 13 R wherein R 1 and R2 are independently hydrogen, C 1 -C 4 alkyl, CI-C 4 haloalkyl, halo, cyano, 5 hydroxy, CI-C 4 alkoxy, C1-C 4 alkylthio, aryl or aryl substituted by one to five R 6 , which 6 may be the same or different, or heteroaryl or heteroaryl substituted by one to five R6 which may be the same or different; R3 is C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl or C 2 -C 4 haloalkynyl; R 4 is aryl or aryl substituted by one to five R8, which may be the same or different, or 10 heteroaryl or heteroaryl substituted by one to four R , which may be the same or different; R 5 is hydroxy or a group which can be metabolised to the hydroxy group; each R 6 and R8 is independently halo, cyano, nitro, CI-Cioalkyl, C 1 -C 4 haloalkyl, C 2 Cioalkenyl, C 2 -Cioalkynyl, hydroxy, C 1 -C 1 oalkoxy, C 1 -C 4 haloalkoxy, C1-Cioalkoxy-Cl 15 C4alkyl-, C 3 -C 7 cycloalkyl, C 3 -C 7 cycloalkoxy, C 3 -C 7 cycloalkyl-C 1 -C 4 alkyl-, C 3 C 7 cycloalkyl-C 1 -C 4 alkoxy-, C 1 -C 6 alkylcarbonyl-, fonnyl, C 1 -C 4 alkoxycarbonyl-, C 1 C 4 alkylcarbonyloxy-, C 1 -Cioalkylthio-, C 1 -C 4 haloalkylthio-, C 1 -C1oalkylsulfinyl-, Ci C 4 haloalkylsulfinyl-, C 1 -C 1 oalkylsulfonyl-, C 1 -C 4 haloalkylsulfonyl-, amino, C 1 Cioalkylamino-, di-C 1 -Cioalkylamino-, C 1 -C 1 oalkylcarbonylamino-, aryl or aryl 20 substituted by one to three R 13 , which may be the same or different, heteroaryl or heteroaryl substituted by one to three R 13 , which may be the same or different, aryl-C 1 C 4 alkyl- or aryl-C 1 -C 4 alkyl- wherein the aryl moiety is substituted by one to three R', which may be the same or different, heteroaryl-C 1 -C 4 alkyl- or heteroaryl-C 1 -C 4 alkyl wherein the heteroaryl moiety is substituted by one to three R ', which may be the same 25 or different, aryloxy- or aryloxy- substituted by one to three R 3 , which may be the same or different, heteroaryloxy- or heteroaryloxy- substituted by one to three R 13 , which may be the same or different, arylthio- or arylthio- substituted by one to three R 1 , which may WO 2008/071918 PCT/GB2007/004662 be the same or different, or heteroarylthio- or heteroarylthio- substituted by one to three R 3 , which may be the same or different; and each R 13 is independently halo, cyano, nitro, CI-C 6 alkyl, CI-C 6 haloalkyl or CI-C 6 alkoxy; or a salt or N-oxide thereof.
[2] 2. A compound according to claim I wherein R' is hydrogen, Ci-C 4 alkyl, C 1 C 4 haloalkyl, halo, cyano, hydroxy or CI-C 4 alkoxy.
[3] 3. A compound according to claim 1 or claim 2 wherein R 2 is hydrogen, C 1 -C 4 alkyl, Ci-C 4 haloalkyl, halo, cyano, hydroxy or CI-C 4 alkoxy. 5
[4] 4. A compound according to any one of claims 1 to 3 wherein R3 is CI-C 4 haloalkyl or C 2 -C 4 haloalkenyl.
[5] 5. A compound according to any one of claims 1 to 4 wherein R3 is 2,2-difluoro ethyl.
[6] 6. A compound according to any one of claims 1 to 5 wherein R 4 is aryl or aryl substituted by one to five R 8 , which may be the same or different.
[7] 7. A compound according to any one of claims 1 to 6 wherein R 5 is hydroxy, R 9 10 oxy-, R1 0 -carbonyloxy-, tri-R 1 -silyloxy- or R1 2 -sulfonyloxy-, wherein R9 is CI-C 1 oalkyl, C 2 -Cioalkenyl, C 2 -Cioalkynyl or aryl-C 1 -C 4 alkyl- or aryl-Ci-C 4 alkyl wherein the aryl moiety is substituted by one to five substituents independently selected from halo, cyano, nitro, C 1 -C 6 alkyl, CI-C 6 haloalkyl or C 1 -C 6 alkoxy; R 1 O is CI-Cioalkyl, C3-Clocycloalkyl, C3-Ciocycloalkyl-C 1 -Cioalkyl-, C1-Ciohaloalkyl, C 2 15 Cioalkenyl, C 2 -Cioalkynyl, C 1 -C 4 alkoxy-C 1 -Cioalkyl-, C 1 -C 4 alkylthio-C 1 -C 4 alkyl-, C 1 C 1 oalkoxy, C 2 -Cioalkenyloxy, C 2 -Cioalkynyloxy, C 1 -C 1 oalkylthio-, N-C 1 -C4alkyl-amino-, 14 N,N-di-(C1-C4alkyl)-amino-, aryl or aryl substituted by one to three R 4, which may be the same or different, heteroaryl or heteroaryl substituted by one to three R 4, which may be the same or different, aryl-C 1 -C 4 alkyl- or aryl-C 1 -C 4 alkyl- wherein the aryl moiety is 20 substituted by one to three R1 4 , which may be the same or different, heteroaryl-C 1 C 4 alkyl- or heteroaryl-C 1 -C 4 alkyl- wherein the heteroaryl moiety is substituted by one to three R1 4 , which may be the same or different, aryloxy- or aryloxy- substituted by one to WO 2008/071918 PCT/GB2007/004662 three R1 4 , which may be the same or different, heteroaryloxy- or heteroaryloxy substituted by one to three R1 4 , which may be the same or different, arylthio- or arylthio substituted by one to three R 1 4 , which may be the same or different or heteroarylthio- or heteroarylthio- substituted by one to three R 4 , which may be the same or different; 5 each R 1 is independently CI-C 1 oalkyl or phenyl or phenyl substituted by one to five substituents independently selected from halo, cyano, nitro, CI-C 6 alkyl, CI-C 6 haloalkyl or CI-C 6 alkoxy; R 1 2 is C1-Cioalkyl, C1-Ciohaloalkyl, or phenyl or phenyl substituted by one to five substituents independently selected from halo, cyano, nitro, Ci-C 6 alkyl, CI-C 6 haloalkyl 10 or C 1 -C 6 alkoxy; and each R 1 4 is independently halo, cyano, nitro, C1-Cioalkyl, C 1 -C 4 haloalkyl, Ci-Cioalkoxy, C 1 -C4alkoxycarbonyl-, C 1 -C4haloalkoxy, C 1 -C1Oalkylthio-, C 1 -C 4 haloalkylthio-, C 1 Cioalkylsulfinyl-, C 1 -C4haloalkylsulfinyl-, C 1 -Cioalkylsulfonyl-, C 1 -C4haloalkylsulfonyl-, aryl or aryl substituted by one to five substituents independently selected from halo, 15 cyano, nitro, C 1 -C 6 alkyl, Ci-C 6 haloalkyl or CI-C 6 alkoxy, or heterdaryl or heteroaryl substituted by one to four substituents independently selected from halo, cyano, nitro, CI C 6 alkyl, C 1 -C 6 haloalkyl or C 1 -C 6 alkoxy.
[8] 8. A compound according to any one of claims 1 to 7 wherein each R6 is independently halo, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C1-C 4 alkoxy or C 1 -C 4 haloalkoxy.
[9] 9. A compound according to any one of claims 1 to 8 wherein each R 8 is independently halo, cyano, nitro, C 1 -Cioalkyl, Ci-C 4 haloalkyl, C 1 -Cioalkoxy, C1 C4alkoxycarbonyl-, Ci-C 4 haloalkoxy, C 1 -C 1 oalkylthio-, C1-C 4 haloalkylthio-, C 1 C1oalkylsulfinyl-, C 1 -C 4 haloalkylsulfinyl-, C 1 -C1oalkylsulfonyl- or C 1 -C 4 haloalkyl sulfonyl-.
[10] 10. A compound according to any one of claims 1 to 9 wherein R 9 is C2-Cloalkenyl, C2-Cioalkynyl, aryl-C 1 -C 4 alkyl- or aryl-C 1 -C 4 alkyl- wherein the aryl moiety is substituted by one to three R" 3 , which may be the same or different.
[11] 11. A compound according to any one of claims I to 10 wherein RI 0 is C1-Cioalkyl-, C 3 -Ciocycloalkyl, Ci-Ciohaloalkyl, C 2 -Cioalkenyl, C 2 -C 1 Oalkynyl, C 1 -C 4 alkoxy-C 1 Cioalkyl-, C 1 -C 4 alkylthio-C 1 -C 4 alkyl-, CI-Cioalkoxy, Ci-Cioalkylthio-, N-C 1 -C 4 alkyl- WO 2008/071918 PCT/GB2007/004662 amino-, NN-di-(CI-C 4 alkyl)-amino-, phenyl or phenyl substituted by one to three R 1 4 , which may be the same or different, benzyl or benzyl wherein the phenyl moiety is substituted by one to three R1 4 , which may be the same or different, thienyl or thienyl substituted by one to three R 1 4 , which may be the same or different, pyridyl or pyridyl substituted by one to three R 1 4 , which may be the same or different, phenoxy or phenoxy substituted by one to three R' 4 , which may be the same or different, or phenylthio or phenylthio substituted by one to three R 4 , which may be the same or different.
[12] 12. A compound according to any one of claims 1 to 11 wherein each R' is independently C-C 4 alkyl.
[13] 13. A compound according to any one of claims 1 to 12 wherein R 12 is C-C 4 alkyl or C-C 4 haloalkyl.
[14] 14. A compound according to any one of claims 1 to 13 wherein each R' 3 is independently halo, nitro, Cr-C 4 alkyl, C 1 -C 4 haloalkyl or C-C 4 alkoxy.
[15] 15. A compound according to any one of claims I to 14 wherein each R 1 4 is independently halo, nitro, C-C 4 alkyl, C 1 -C 4 haloalkyl, C-C 4 alkoxy or C 1 -C 4 haloalkoxy.
[16] 16. A method of controlling plants which comprises applying to the plants or, to the locus thereof a herbicidally effective amount of a compound of formula (I) as defined in any one of claims I to 15.
[17] 17. A herbicidal composition which comprises a herbicidally effective amount of a compound of formula (I) as defined in any one of claims 1 to 15 in addition to formulation adjuvants.
[18] 18. A herbicidal composition which comprises a herbicidally effective amount of a compound of fonnula (I) as defined in any one of claims 1 to 15, optionally one or more further herbicides, and optionally one or more safeners.

类似技术:

---

公开号 | 公开日 | 专利标题

---

AU2007331307B2|2012-02-16|Pyrido-pyrazine derivatives useful as herbicidal compounds

---

US8653078B2|2014-02-18|Herbicidal pyrido[2,3-b]pyrazines

---

EP2057154B1|2012-11-14|Pyrido [2, 3-b]pyrazine derivatives useful as herbicidal compounds

---

AU2009204687B2|2014-04-10|Herbicidal compounds

同族专利:

---

公开号 | 公开日

---

MX2009005616A|2009-06-08|

---

CY1110956T1|2015-06-11|

---

UA99908C2|2012-10-25|

---

BRPI0720055B1|2014-12-09|

---

PL2102205T3|2011-02-28|

---

CA2671472C|2015-11-03|

---

WO2008071918A1|2008-06-19|

---

KR20090087473A|2009-08-17|

---

PT2102205E|2010-11-18|

---

AU2007331307B2|2012-02-16|

---

US8217055B2|2012-07-10|

---

EA200970569A1|2009-12-30|

---

BRPI0720055A2|2013-12-17|

---

AT479685T|2010-09-15|

---

NZ577059A|2011-03-31|

---

WO2008071918A8|2009-07-02|

---

EP2102205A1|2009-09-23|

---

DE602007008946D1|2010-10-14|

---

AR064124A1|2009-03-11|

---

RS51430B|2011-04-30|

---

EP2102205B1|2010-09-01|

---

SI2102205T1|2011-01-31|

---

GB0624760D0|2007-01-17|

---

CA2671472A1|2008-06-19|

---

JP2010512375A|2010-04-22|

---

EA015647B1|2011-10-31|

---

ES2351676T3|2011-02-09|

---

HRP20100656T1|2011-01-31|

---

CN101605785A|2009-12-16|

---

DK2102205T3|2010-12-06|

---

CL2007003539A1|2008-05-30|

---

CN101605785B|2013-04-10|

---

JP5319545B2|2013-10-16|

---

CO6220882A2|2010-11-19|

---

ZA200904108B|2010-04-28|

---

US20100167929A1|2010-07-01|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

US5110347A|1990-11-26|1992-05-05|E. I Du Pont De Nemours And Company|Substituted fused heterocyclic herbicides|

---

GB0230020D0|2002-12-23|2003-01-29|Syngenta Ltd|Fungicides|

---

EA200600214A1|2003-07-18|2006-08-25|Басф Акциенгезельшафт|ARYL-CONDENSED 3-ARYLPYRIDINE COMPOUNDS AND THEIR APPLICATION TO FIGHT PATHOGENIC MUSHROOMS|

---

GB0413955D0|2004-06-22|2004-07-28|Syngenta Participations Ag|Chemical compounds|

---

GB0413953D0|2004-06-22|2004-07-28|Syngenta Participations Ag|Chemical compounds|

---

GB0614471D0|2006-07-20|2006-08-30|Syngenta Ltd|Herbicidal Compounds|GB0614471D0|2006-07-20|2006-08-30|Syngenta Ltd|Herbicidal Compounds|

---

US8097712B2|2007-11-07|2012-01-17|Beelogics Inc.|Compositions for conferring tolerance to viral disease in social insects, and the use thereof|

---

GB0800855D0|2008-01-17|2008-02-27|Syngenta Ltd|Herbicidal compounds|

---

GB0816880D0|2008-09-15|2008-10-22|Syngenta Ltd|Improvements in or relating to organic compounds|

---

AU2009309837A1|2008-10-29|2010-05-06|Basf Se|Substituted pyridines having a herbicidal effect|

---

MX2011009188A|2009-03-11|2011-09-26|Bayer Cropscience Ag|Halogenalkylmethylenoxy-phenyl-substituted ketoenols.|

---

EP2438071A1|2009-06-05|2012-04-11|Basf Se|Substituted pyrazine pyrans with a herbicidal action|

---

US8962584B2|2009-10-14|2015-02-24|Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd.|Compositions for controlling Varroa mites in bees|

---

DE102010042867A1|2009-10-28|2011-06-01|Basf Se|Use of heterocyclic compounds as herbicides and for controlling undesirable plants in culture of useful plants e.g. wheat, barley, rye, oats, millet and rice|

---

WO2011051212A1|2009-10-28|2011-05-05|Basf Se|Use of heteroaromatic compounds as herbicides|

---

DE102010042866A1|2009-10-30|2011-05-05|Basf Se|New thioamide compounds, useful for controlling undesirable plant growth or weeds in cultural plants e.g. Arachis hypogaea, Allium cepa, Elaeis guineensis and Gossypium herbaceum|

---

US8329619B2|2009-11-03|2012-12-11|Basf Se|Substituted quinolinones having herbicidal action|

---

WO2011057989A1|2009-11-11|2011-05-19|Basf Se|Heterocyclic compounds having herbicidal action|

---

WO2011057942A1|2009-11-12|2011-05-19|Basf Se|Insecticidal methods using pyridine compounds|

---

WO2011058036A1|2009-11-13|2011-05-19|Basf Se|Tricyclic compounds having herbicidal action|

---

US9121022B2|2010-03-08|2015-09-01|Monsanto Technology Llc|Method for controlling herbicide-resistant plants|

---

BR112012023936A2|2010-03-23|2015-09-15|Basf Se|substituted pyridazine of formula i, compound for formula i, composition and method for controlling unwanted vegetation|

---

AR081526A1|2010-03-23|2012-10-03|Basf Se|PIRIDAZINAS REPLACED THAT HAVE HERBICITY ACTION|

---

EP2550276A1|2010-03-23|2013-01-30|Basf Se|Substituted pyridines having herbicidal action|

---

JP2013522341A|2010-03-23|2013-06-13|ビーエーエスエフソシエタス・ヨーロピア|Substituted pyridazines with herbicidal action|

---

JP2013522340A|2010-03-23|2013-06-13|ビーエーエスエフソシエタス・ヨーロピア|Substituted pyridines with herbicidal action|

---

EA201201322A1|2010-03-23|2013-05-30|Басф Се|Pyridine, possessing herbicidal action|

---

WO2011145015A1|2010-05-04|2011-11-24|Basf Se|Plants having increased tolerance to herbicides|

---

JP5990170B2|2010-09-01|2016-09-07|バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ|Ketosultams and diketopyridines with herbicidal activity|

---

EP2638019A1|2010-11-12|2013-09-18|Syngenta Limited|Herbicidal compounds|

---

KR20130130795A|2010-12-23|2013-12-02|바스프 에스이|Substituted pyridines having herbicidal activity|

---

EP2704561B1|2011-05-05|2016-08-03|Dow AgroSciences LLC|Stable high strength oil-in-water emulsions|

---

US10829828B2|2011-09-13|2020-11-10|Monsanto Technology Llc|Methods and compositions for weed control|

---

EP2755987B1|2011-09-13|2018-06-06|Monsanto Technology LLC|Methods and compositions for weed control|

---

UA115534C2|2011-09-13|2017-11-27|Монсанто Текнолоджи Ллс|Methods and compositions for weed control|

---

US10806146B2|2011-09-13|2020-10-20|Monsanto Technology Llc|Methods and compositions for weed control|

---

US10760086B2|2011-09-13|2020-09-01|Monsanto Technology Llc|Methods and compositions for weed control|

---

EP3382027A3|2011-09-13|2018-10-31|Monsanto Technology LLC|Methods and compositions for weed control|

---

MX350773B|2011-09-13|2017-09-15|Monsanto Technology Llc|Methods and compositions for weed control.|

---

BR112014005979A2|2011-09-13|2017-06-13|Monsanto Technology Llc|Weed control methods and compositions|

---

EP3296402B1|2011-09-13|2020-04-15|Monsanto Technology LLC|Methods and compositions for weed control|

---

WO2013040057A1|2011-09-13|2013-03-21|Monsanto Technology Llc|Methods and compositions for weed control|

---

MX2014004882A|2011-11-02|2014-10-17|Basf Se|Plants having increased tolerance to herbicides.|

---

US10240162B2|2012-05-24|2019-03-26|A.B. Seeds Ltd.|Compositions and methods for silencing gene expression|

---

BR112015005674A2|2012-09-14|2017-08-08|Bayer Cropscience Ag|hppd variants and methods of use|

---

WO2014097085A1|2012-12-18|2014-06-26|Basf Se|Herbicide-metabolizing cytochrome p450 monooxygenases|

---

WO2014106837A2|2013-01-01|2014-07-10|A. B. Seeds Ltd.|ISOLATED dsRNA MOLECULES AND METHODS OF USING SAME FOR SILENCING TARGET MOLECULES OF INTEREST|

---

US10683505B2|2013-01-01|2020-06-16|Monsanto Technology Llc|Methods of introducing dsRNA to plant seeds for modulating gene expression|

---

UA123082C2|2013-03-13|2021-02-17|Монсанто Текнолоджи Ллс|Methods and compositions for weed control|

---

WO2014164797A2|2013-03-13|2014-10-09|Monsanto Technology Llc|Methods and compositions for weed control|

---

US10568328B2|2013-03-15|2020-02-25|Monsanto Technology Llc|Methods and compositions for weed control|

---

WO2014177991A2|2013-04-30|2014-11-06|Basf Se|Plants having increased tolerance to herbicides|

---

US10829778B2|2013-04-30|2020-11-10|Basf Se|Plants having increased tolerance to herbicides|

---

PL3030663T3|2013-07-19|2020-04-30|Monsanto Technology Llc|Compositions and methods for controlling leptinotarsa|

---

US9850496B2|2013-07-19|2017-12-26|Monsanto Technology Llc|Compositions and methods for controlling Leptinotarsa|

---

GB201319411D0|2013-11-01|2013-12-18|Syngenta Ltd|Herbicidal compounds|

---

CN105849266A|2013-11-04|2016-08-10|孟山都技术公司|Compositions and methods for controlling arthropod parasite and pest infestations|

---

EP3080147B1|2013-12-10|2019-03-13|Beeologics, Inc.|Compositions and methods for virus control in varroa mite and bees|

---

AU2015206585A1|2014-01-15|2016-07-21|Monsanto Technology Llc|Methods and compositions for weed control using EPSPS polynucleotides|

---

MX2016011745A|2014-03-11|2017-09-01|Bayer Cropscience Lp|Hppd variants and methods of use.|

---

BR112016022711A2|2014-04-01|2017-10-31|Monsanto Technology Llc|compositions and methods for insect pest control|

---

CN106795515B|2014-06-23|2021-06-08|孟山都技术公司|Compositions and methods for modulating gene expression via RNA interference|

---

RU2021123470A|2014-07-29|2021-09-06|Монсанто Текнолоджи Ллс|COMPOSITIONS AND METHODS FOR COMBATING PESTS|

---

CA2974101A1|2015-01-22|2016-07-28|Monsanto Technology Llc|Compositions and methods for controlling leptinotarsa|

---

AU2016270870A1|2015-06-02|2018-01-04|Monsanto Technology Llc|Compositions and methods for delivery of a polynucleotide into a plant|

---

WO2016196782A1|2015-06-03|2016-12-08|Monsanto Technology Llc|Methods and compositions for introducing nucleic acids into plants|

---

CA2998036A1|2015-09-11|2017-03-16|Bayer Cropscience Aktiengesellschaft|Hppd variants and methods of use|

---

BR112019018056A2|2017-03-07|2020-08-11|BASF Agricultural Solutions Seed US LLC|recombinant nucleic acid molecule, expression cassette, host cell, plants, transgenic seeds, recombinant polypeptide, methods for checking tolerance and for controlling weeds, utility product and use of the nucleotide sequence|

---

CA3055389A1|2017-03-07|2018-09-13|BASF Agricultural Solutions Seed US LLC|Hppd variants and methods of use|

---

WO2019083810A1|2017-10-24|2019-05-02|Basf Se|Improvement of herbicide tolerance to 4-hydroxyphenylpyruvate dioxygenaseinhibitors by down-regulation of hppd expression in soybean|

---

BR112020008096A2|2017-10-24|2020-11-03|Basf Se|method for checking tolerance to a GM herbicide and soy plant|

法律状态:
2009-08-13| DA3| Amendments made section 104|Free format text: THE NATURE OF THE AMENDMENT IS: AMEND CO-INVENTOR FROM CROWLEY, PATRICK JEFF TO CROWLEY, PATRICK JELF |

---

2012-06-14| FGA| Letters patent sealed or granted (standard patent)|

---

2019-07-04| MK14| Patent ceased section 143(a) (annual fees not paid) or expired|

优先权:

---

申请号 | 申请日 | 专利标题

---

GB0624760.5||2006-12-12||

---

GBGB0624760.5A|GB0624760D0|2006-12-12|2006-12-12|Herbicidal compounds|

---

PCT/GB2007/004662|WO2008071918A1|2006-12-12|2007-12-06|Pyrido-pyrazine derivatives useful as herbicidal compounds|

---